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Abstract 
CLIC1 is an intracellular membrane protein that has an unusual property distinct from typical 
membrane proteins. It is able to exist in both a soluble and membrane-bound form in cells. 
The membrane-insertion mechanism of soluble CLIC1 is still unknown. However, it has been 
proposed that soluble CLIC1 has to undergo unfolding and refolding processes to form its 
membrane-bound conformation. In this study, the focus is on the understanding of the 
unfolding mechanism of soluble CLIC1 under the pH values typical of the cytosol and the 
membrane surface. Equilibrium unfolding studies show that, at pH 7.0, CLIC1 unfolds via a 
two-state transition and the unfolding kinetics studies further confirms that there are no 
detectable transient intermediates. At pH 5.5, CLIC1 shows a three-state unfolding transition 
with a formation of an intermediate species at equilibrium in the presence of 3 ~ 4 M urea. 
The characterisation of this intermediate indicates that it has reduced secondary structural 
content and native-like tertiary structure with the exception of a more buried Trp35 when 
compared to the native state. Moreover, this intermediate has more exposed hydrophobic 
surface than the native state. The unfolding kinetics studies demonstrate that there are hidden 
intermediates in the native-to-unfolded transition at pH 5.5. The formation of the intermediate 
state involves, initially, a rapid partial unfolding followed by a slow repacking of the structure. 
The results from equilibrium unfolding and unfolding kinetics studies both suggest that the 
intermediate state is more stable than the native state at pH 5.5, indicating that under this 
condition, the stability of native CLIC1 is reduced and the intermediate is energetically 
favoured. The results from this study give information about the conformational stability and 
the different unfolding behaviours of soluble CLIC1 under the conditions that simulate the 
environments of the cytosol and the membrane surface, and further provide a possible 
interpretation for the in vivo membrane-insertion mechanism of the protein. 
 
 III 
Acknowledgements 
 
I wish to acknowledge my supervisor, Dr. Sylvia Fanucchi, for her support and guidance 
throughout my research. Her unflagging enthusiasm and dedication to the cause has been a 
source of strength and inspiration. In addition, special thanks are due to my co-supervisor, 
Professor Heini Dirr, who kept a close watch on proceedings and whose sometimes stern 
approach helped to keep me focused and engaged. I am also grateful to all of my colleagues 
in the Protein Structure Function Research Unit for their help and advice in the lab and for 
their great friendship.     
 
 
 
 
 
 
 
 
 
 
 
 
 IV 
Table of contents 
 
Declaration.................................................................................................................................I 
Abstract.................................................................................................................................... II 
Acknowledgements ................................................................................................................ III 
Abbreviations .........................................................................................................................VI 
List of figures........................................................................................................................ VII 
List of tables............................................................................................................................IX 
1. Introduction..........................................................................................................................1 
1.1. Protein folding...........................................................................................................1 
1.1.1. The protein folding mechanism ....................................................................1 
1.2. Unfolding of proteins ..............................................................................................10 
1.2.1. Equilibrium unfolding .................................................................................10 
1.2.2. Unfolding kinetics and unfolding pathways ..............................................13 
1.3. Metamorphic proteins ............................................................................................20 
1.4. Soluble proteins that insert into membranes........................................................22 
1.5. Chloride intracellular channels .............................................................................23 
1.6. Overview of CLIC1.................................................................................................24 
1.6.1. Structure of soluble CLIC1 .........................................................................24 
1.6.1.1. Primary sequence and secondary structure ...................................24 
1.6.1.2. Tertiary structure ..............................................................................26 
1.6.2. The factors influencing CLIC1 membrane-insertion in vitro ..................29 
1.6.2.1. Redox condition.................................................................................29 
1.6.2.2. The effect of pH.................................................................................31 
1.7. Objective ..................................................................................................................33 
2. Experimental procedures ..................................................................................................35 
2.1. Materials ..................................................................................................................35 
2.2. Methods....................................................................................................................35 
2.2.1. Expression and purification of recombinant CLIC1 ................................35 
2.2.2. Confirmation of protein purity ...................................................................38 
2.2.3. Determination of protein concentration ....................................................40 
2.2.4. Structural characterisation of CLIC1 ........................................................41 
2.2.5. Urea-induced equilibrium unfolding..........................................................45 
2.2.6. Unfolding kinetics ........................................................................................53 
3. Results .................................................................................................................................56 
3.1. CLIC1 expression and purification .......................................................................56 
3.2. Structural characterisation of CLIC1...................................................................61 
 V 
3.3. Urea-induced equilibrium unfolding.....................................................................65 
3.3.1. Recovery studies...........................................................................................65 
3.3.2. Effect of pH on the conformational stability of CLIC1............................67 
3.3.3. Structure of the intermediate ......................................................................72 
3.4. Unfolding kinetics ...................................................................................................77 
4. Discussion............................................................................................................................86 
4.1. A stable equilibrium intermediate state of CLIC1 is formed at pH 5.5 .............86 
4.2. Unfolding of CLIC1 ................................................................................................89 
4.2.1. The appearance of hidden intermediates in the N →U transition...........90 
4.2.2. The equilibrium intermediate is more stable than the native state at   
pH 5.5 ...........................................................................................................90 
4.2.3. Formation of the equilibrium intermediate...............................................91 
4.2.4. Unfolding pathway of CLIC1 .....................................................................94 
4.3. Proposed CLIC1 insertion mechanism .................................................................96 
4.4 Conclusions...............................................................................................................99 
5. References .........................................................................................................................101 
 
 
 
 
 
 
 
 
 
 
 
 VI 
Abbreviations 
 
A260 Absorbance at 260 nm 
A280 Absorbance at 280 nm 
Å Ångström 
ANS 8-anilino-1-napthalene sulfonate 
CD Circular dichroism 
CLIC Chloride intracellular channel 
Cm The denaturant concentration at which the native and the unfolded 
species are equally populated 
cm centimeter 
DEAE Diethylaminoethyl 
DTT Dithiothreitol 
∆G Change in Gibbs free energy 
∆G(H2O) Change in Gibbs free energy between native state and unfolded state 
in the absence of denaturant in equilibrium unfolding studies  
ε280 Molar extinction coefficient at 280 nm 
E222 CD ellipticity measured at 222 nm 
F310 Fluorescence intensity at 310 nm 
F345 Fluorescence intensity at 345 nm 
Far-UV CD Far-ultraviolet circular dichroism 
GSH Reduced glutathione 
GST Glutathione transferase 
I Intermediate state 
IAEW Intensity averaged emission wavelength 
IPTG Isopropyl β-D-thiogalactopyranoside 
kDa kilodalton 
M Molar 
N Native state 
OD600 Optical density at 600 nm 
PDB Protein Data Bank 
pI Isoelectric point 
rpm Revolutions per minute 
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
U Unfolded state 
 
 
 VII 
List of figures 
 
Figure 1: Representative protein folding funnels..................................................................2 
 
Figure 2: Different states that a polypeptide chain can form ..............................................8 
 
Figure 3: Amino acid sequence and secondary structural elements of CLIC1 ................25 
 
Figure 4: Crystal structure of soluble reduced CLIC1 ......................................................27 
 
Figure 5: Structure of dimeric oxidised CLIC1 ..................................................................30 
 
Figure 6: SDS-PAGE gels illustrating a representative purification process of CLIC1..57 
 
Figure 7: Calibration curve obtained from the SDS-PAGE gel.........................................59 
 
Figure 8: Absorbance spectrum of purified CLIC1............................................................60 
 
Figure 9: Comparison of the circular dichroism spectra of CLIC1 at pH 7.0 and pH 5.5
..................................................................................................................................................62 
 
Figure 10: Comparison of the fluorescence spectra of CLIC1 at pH 7.0 and pH 5.5......64 
 
Figure 11: Recovery of secondary and tertiary structure of CLIC1 .................................66 
 
Figure 12: Equilibrium unfolding of CLIC1 at pH 7.0 and pH 5.5...................................68 
 
Figure 13: Fractional populations plot of CLIC1 as a function of urea concentrations at 
pH 5.5 ......................................................................................................................................71 
 
Figure 14: Comparison of CD spectra of the native and the intermediate state..............73 
 
Figure 15: Comparison of tryptophan fluorescence spectra of the native and the 
intermediate state of CLIC1 .................................................................................................74 
 
Figure 16: ANS binds to the intermediate state of CLIC1 .................................................76 
 
 VIII 
Figure 17: Representative unfolding kinetic traces for the N →U transition at pH 7.0 
and pH 5.5...............................................................................................................................78 
 
Figure 18: Urea dependence of the unfolding rate constants.............................................79 
 
Figure 19: Representative unfolding kinetic traces of CLIC1 from the N → I transition 
at pH 5.5 ..................................................................................................................................83 
 
Figure 20: Representative unfolding kinetic traces of the I →U transition .....................85 
 
Figure 21: Proposed unfolding pathway of CLIC1.............................................................95 
 
Figure 22: Proposed membrane insertion model of CLIC1...............................................97 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 IX 
List of tables 
 
Table 1: List of diseases caused by protein misfolding and the related proteins and 
peptides ...................................................................................................................................7 
 
Table 2: Comparison of the thermodynamic parameters obtained from the equilibrium 
unfolding studies at pH 7.0 and pH 5.5................................................................................69 
 
Table 3: Parameters of the unfolding kinetics of CLIC1 at pH 7.0 and pH 5.5 ...............80 
 
 
 
 
 
 
 
 
 
 
 
 
 1 
1. Introduction 
1.1. Protein folding 
Proteins are the molecules that are necessary for various biological activities and diverse 
physiological processes. After synthesis in the ribosomes, long polypeptide chains need to be 
converted into specific native three-dimensional conformations in order to conduct their 
functions. This process is called protein folding. Since the function of a protein is determined 
to a large extent by its native structure, the failure of proteins to fold correctly is often the 
cause of disorders. These diseases such as Alzheimer’s disease are the result of misfolding 
and aggregation of certain proteins (reviewed by Ecroyd and Carver, 2008). Therefore, the 
study of protein folding is critical for getting insight into the correct folding mechanism. Only 
when we understand the folding mechanism, will we be able to know how a protein acquires 
its native structure and performs its biological function. An understanding of protein folding 
also allows us to reveal the pathogenic mechanism of various misfolding disorders and 
further to seek the cure for these diseases. 
 
1.1.1. The protein folding mechanism 
Energy landscape theory 
Many different models have been used to explain the protein folding mechanism (Chan et al., 
1995; Dobson and Karplus, 1999; Rumbley et al., 2001; Clark, 2004). Subsequently, a 
general theory was developed in an attempt to explain all of the current folding models 
(reviewed by Dobson, 2004). This theory uses an energy landscape to describe the protein 
folding process. An energy landscape used to indicate protein folding generally has a 
funnel-like shape with a wide top and a minimum point, and is therefore called a protein 
folding funnel (Figure 1). The x-axis of the funnel represents the conformational entropy of a 
polypeptide chain. The y-axis is the free energy associated with the stabilisation of the  
 2 
 
 
 
 
 
Figure 1: Representative protein folding funnels 
Unfolded proteins can exist in different random structures. The width of the protein folding 
funnels represents the conformational entropy. The depth represents the free energy of the 
current structure of the polypeptide chain. As the unfolded proteins fold, they follow the 
landscape downwards as their structures assume lower energy conformations. This process 
terminates with the formation of structures with the lowest energy (the native states). (A) 
represents a smooth folding landscape without any stable intermediates. (B) represents a 
more complicated folding landscape with existence of intermediates. This figure was 
obtained from Bartlett and Radford, 2009.  
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Intermediate 
Intermediate 
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Energy 
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polypeptide chain. An unfolded polypeptide chain is able to exist in a large number of 
different low-energy conformations that can transform between each other rapidly, and thus 
the top of the folding funnel is wide. The correct (native-like) interactions between residues 
are relatively more stable than the incorrect (non-native) interactions and thus finally lead the 
polypeptide chain to fold along the funnel to the structure with the lowest free energy at the 
minimum of the funnel (Dobson, 2004). 
 
The presence or absence of local energy minima results in the ruggedness of energy 
landscapes. For some small proteins, the energy landscape might be relatively smooth (Figure 
1A). However, the energy landscapes of larger proteins are often rugged and have local 
minima (Figure 1B). This phenomenon may explain why protein folding is so complex. Since 
a folding funnel is three-dimensional and polypeptide chains are able to fold along the folding 
funnel to the lowest energy point of the folding funnel from different start points, each 
protein molecule is able to follow different routes to the native state depending on 
environmental conditions and thus different structures can be formed from different 
native-like interactions among residues along the folding pathway (Szilágyi et al., 2007). 
 
Since some routes are smooth and the others are bumpy, the route which a polypeptide chain 
takes has an influence on its folding rate. An energy barrier, known as the transition state, is 
defined as the energy peak in the folding pathway between the native and unfolded states that 
proteins need to overcome (Onuchic et al., 1996 and 1997; Onuchic and Wolynes, 2004). 
There can be many energy barriers along a single folding pathway, however, the transition 
state corresponds to the energy barrier with the highest activation energy and thus will be the 
main rate-limiting step of the overall reaction (Daggett and Fersht, 2000). Different obstacles 
along different folding routes result in local rate-limiting steps in the folding of a protein. For 
example, a folding protein trapped in a local energy landscape minimum has an energy 
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barrier to overcome before it can fold to the native state. The obstacles for protein folding do 
not only come from energy barriers but also from entropic barriers. For example, random 
search for stable interactions or structures to continue the folding process can also be 
rate-limiting (Dill and Chan, 1997). Proline cis-trans isomerisation and the formation of 
disulfide bonds in proteins are also causes of slow processes in protein folding. These two 
mechanisms will be discussed later on. 
 
Folding intermediates 
The energy landscape for small proteins (less than 100 residues) is often smoother than for 
large proteins and thus the small proteins often fold following a two-state process without 
formation of any intermediate states (Jackson, 1998). In contrast, proteins with more than 100 
residues generally fold along pathways that involve the population of intermediate species 
under certain conditions such as high salt concentration or low pH (Dobson et al., 1998; 
Fersht, 1999). As mentioned previously, the transition state is the main energy barrier to the 
overall folding process. The ensemble of all intermediate states (both transient and 
equilibrium intermediates) on-pathway to the native state can be seen as the transition state of 
the overall folding reaction (Dobson and Karplus, 1999). 
 
It has been shown that intermediate species formation can either accelerate or slow down the 
protein folding processes depending on whether they are formed before or after the 
rate-limiting step on the folding pathway (Ellison and Cavagnero, 2006; reviewed by 
Udgaonkar, 2008). The intermediate states that are required to lead proteins to fold to the 
native state are so called “on-pathway” intermediates. If these on-pathway intermediates form 
after the rate-limiting step, their conformations involving critical interactions are able to 
facilitate protein folding by reducing the numbers of possible structures available to the 
folding protein (Rami and Udgaonkar, 2002). Moreover, sometimes point mutations in 
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proteins can block the formation of stable intermediate states and thus interrupt the normal 
protein folding causing diseases (Bychkova and Ptitsyn, 1995; Ptitsyn et al., 1995).  
 
A certain distinctive intermediate state has been identified in many different proteins. It has 
common features described as well-packed secondary structures with flexible side chains and 
exposed hydrophobic cores. This protein conformation was named the “molten globule” by 
Ohgushi and Wada in 1983 (Ohgushi and Wada, 1983). In 1985 and 1986, the molten globule 
state of α-lactalbumin was shown to be identical to its transient folding intermediate by 
Kuwajima et al., 1985 and Ikeguchi et al., 1986. After this, the molten globule state has been 
thought to be a common folding intermediate state in numerous proteins (Kuwajima, 1989; 
Ptitsyn, 1995; Arai and Kuwajima, 2000). However, not all the molten globule states are 
related exclusively to the protein folding process. Some molten globules are involved in 
specific biological processes such as membrane insertion (Van der Goot et al., 1991), 
transmembrane trafficking (Hartl et al., 1994) and chaperone-assisted refolding (Kuwajima and 
Arai, 2000)  
 
Despite the intermediate states which lead proteins to fold, some intermediate structures 
which accumulate during the folding reaction are not necessary for protein folding and in 
many cases actually impede the process. These intermediate states are usually misfolded 
structures “trapped” in the local minima of the folding funnel and require complete or, at least, 
partial unfolding to be corrected and continue folding to the correct native state (Evan et al., 
2005). This kind of intermediate state is called “off-pathway”. It has been shown that these 
transient off-pathway intermediate species are able to cause various diseases which result 
from protein misfolding (reviewed by Santucci et al., 2008). 
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Protein misfolding 
As mentioned in the beginning of this chapter, it is necessary for proteins to have the correct 
structures, and retain the correct conformations in order to function. Furthermore, it has been 
shown that failures in protein folding are strongly correlated with various human diseases 
(Dobson, 2003 and 2004). These diseases are so-called “conformational” or “misfolding” 
diseases. Some of these diseases simply result from the fact that misfolded proteins cannot 
function properly. In other cases, the diseases are caused by the formation of misfolded 
aggregates that are toxic to the cell. A summary of misfolding disorders and the related 
proteins or peptides is shown in Table 1. 
 
The causes of protein misfolding include amino acid composition and environmental 
conditions. Certain mutations are also known to induce misfolding. Protein misfolding is 
dependent on the environmental conditions (reviewed by Herczenik and Gebbink, 2008). 
Specific conditions such as extreme pH, increased temperature, agitation, elevated glucose, 
and oxidative agents are able to destabilise the native protein conformation and further cause 
the unfolding or partial unfolding of the proteins. As seen in Figure 1, the unfolded state has a 
high free energy and is thus thermodynamically unstable and unfavourable. Therefore, 
unfolded proteins are prone to form aggregates in order to lower the free energy.  
 
The possible fates of a polypeptide chain are demonstrated in Figure 2. It is possible for a 
polypeptide chain to form aggregates from every structural state depending on the 
environment. Furthermore, there are certain factors that serve as precursors for the initiation 
of aggregation processes such as exposed hydrophobic segments on proteins, β-sheet content, 
low net charge (Linding et al., 2004) and peptide segments from incomplete/incorrect 
proteolysis (Stix et al., 2001) or partial unfolded structures such as off-pathway intermediates 
(Laidman et al., 2006).  
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Table 1: List of diseases caused by protein misfolding and the related proteins and  
peptides 
 
Disease Associated proteins Affected tissues 
Amyloidosis – systemic 
Primary systemic amyloidosis 
Ig heavy-chain-associated amyloidosis 
Secondary (reactive) systemic amyloidosis 
Senile systemic amyloidosis 
Hemodialysis-related amyloidosis 
Hereditary systemic ApoAI amyloidosis 
Hereditary systemic ApoAII amyloidosis 
Finnish herefitary amyloidosis 
Hereditary lysozyme amyloidosis 
Hereditary cystatin C amyloid angiopathy 
 
Ig light chain 
Ig heavy chain 
SAA 
Transthyretin 
β2 – Microglobulin 
ApoAI 
ApoAII 
Gelsolin 
Lysozyme 
Cystatin C 
 
Most tissues 
Most tissues 
Most tissues 
Microvasculature 
Osteoarticular tissues 
Liver, kidney, heart 
Kidney, heart 
Most tissues 
Kidney, liver 
Most tissues 
Amyloidosis – localised 
Injection-localised amyloidosis 
Hereditary renal amyloidosis 
Senile seminal vesicle amyloid 
Familial subepithelial corneal amyloidosis 
Cataract 
Medullary thyroid carcinoma 
 
Insulin 
Fibrinogen 
Lactoferrin, seminogelin 
Lactoferrin 
Crystallin 
Calcitonin 
 
Skin, muscles 
Kidney 
Seminal vesicles 
Cornea 
Eye 
Thyroid tissues 
Neurodegenerative diseases 
Alzheimer’s disease 
Parkinson’s disease 
Lewy-body dementia 
Huntington’s disease 
Spongiform encephalopathies 
Hereditary cerebral hemorrhage with 
amyloidosis 
Amyotrophic lateral sclerosis 
Familial British dementia 
Familial Danish dementia 
Familial amyloidotic polyneuropathy  
Frontotemporal dementias 
 
Amyloid-β, tau 
α-Synuclein 
α-Synuclein 
Huntington 
Prion 
Cystatin C 
 
Superoxide dismutase 1 
Abri 
ADan, amyloid-β 
Transthyretin 
Tau 
 
Brain 
Brain 
Brain 
Brain 
Brain, peripheral nervous system 
Cerebral vasculature 
 
Brain 
Brain 
Brain 
Peripheral nervous system 
Brain 
Other diseases 
Diabetes mellitus 
Atherosclerosis 
Sickle cell anemia 
 
IAPP, amylin 
Modified LDL 
Hemoglobin 
 
Pancreas (islet) 
Arteries 
Erythrocytes 
 
This table was obtained from Herczenik and Gebbink, 2008. 
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Figure 2: Different states that a polypeptide chain can form 
After synthesis on ribosomes, a polypeptide chain is able to fold to its monomeric native 
structure, with or without involvement of partially folded intermediates. It can also 
experience different fates such as aggregation, amyloid formation and degradation. Native 
protein fibres, functional oligomers and protein crystals produced in vitro for X-ray 
diffraction structural studies are all formed by association of the monomers of native 
structures. The interconversion and population of different states depends on the 
thermodynamic and kinetic stabilities under different environmental conditions. This figure 
was obtained from Dobson, 2003. 
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There are three kinds of protein forms that are related to misfolding disorders: soluble 
oligomers, amorphous aggregates and amyloid fibrils. The factors that determine whether a 
protein forms amyloid fibrils, amorphous aggregates or soluble oligomers during the 
aggregation process are the amino acid sequence of the protein and the environmental 
conditions (reviewed by Uversky and Fink, 2004). Soluble oligomers are often precursors for 
the formation of amorphous aggregates and amyloid fibrils. Amorphous aggregates refer to 
the aggregated proteins that do not form locally ordered structure. In contrast with amorphous 
aggregates, amyloid fibrils have a highly organised, long unbranched structure that resembles 
a hollow tube. Different from other naturally occurring biological fibrils which often contain 
helices, amyloid fibrils formed from different proteins share a common cross-β secondary 
structure (Meredith, 2005; reviewed by Herczenik and Gebbink, 2008). These tubular 
structures are normally formed by two to six “profilaments” twisting around one another. The 
formation of amyloid fibrils involves interactions between different polypeptide main chains 
and the whole structure is mainly stabilised by hydrogen bonds (Dobson, 2004). Although the 
amyloid fibril is only one of the various aggregation types, it bears a significant feature. Since 
the structure of amyloid fibril is highly organised, it has unique kinetic stability compared to 
the other kinds of aggregate (Dobson, 2003). Such aggregates are able to persist for long 
periods of time in cells instead of being degraded by proteosomes. This further allows the 
formation of additional amyloid deposit in different tissues. In fact, they can even induce the 
conversion of the same protein into amyloid fibrils (Dobson, 2003). Since it has unique 
properties and it is involved in pathogenesis of various disorders, amyloid fibrils have been 
the most extensively studied among the three types of aggregation.  
 
 
 
 10 
1.2. Unfolding of proteins 
Despite the fact that protein folding is essential for proteins to perform their activities, the 
unfolding of many proteins is also an important physiological process and may be needed for 
their complete function (reviewed by Fersht and Daggett, 2002). For example, unfolding is 
important for protein degradation via the proteasome (Baumeister et al., 1998). In addition, 
transient unfolding is also an important process to facilitate soluble proteins that lack a leader 
sequence to insert into membranes post-translationally (reviewed by Zakharov and Cramer, 
2002; reviewed by Matouschek, 2003). Moreover, natively unfolded proteins exist that are 
functional in their unfolded states because their highly flexible conformations allow a more 
efficient interaction between them and their several different targets (Wright and Dyson, 
1999; Dunker et al., 2001; reviewed by Uversky, 2002). Also, as mentioned previously, the 
unfolding process is sometimes related to certain protein misfolding diseases where partially 
unfolded intermediate states of certain proteins are the main cause of these diseases 
(reviewed by Dobson, 2004; Ecroyd and Carver, 2008). Since protein unfolding is involved 
in various important biological processes, both functional and disease-causing, the unfolding 
of proteins is often studied to acquire more information about the mechanism of action of 
these proteins or in order to understand the pathogenesis of various diseases and to develop 
therapies for these disorders. 
 
The unfolding mechanism of a protein can be observed experimentally in two ways either via 
equilibrium unfolding or via unfolding kinetics. 
 
1.2.1. Equilibrium unfolding 
Equilibrium unfolding is a method used to study protein unfolding. The native state of a 
protein exists in equilibrium with the unfolded state. Simply changing in the environment to 
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perturb this equilibrium can cause it to shift so that one state becomes more or less populated 
than the other. In this method, protein can be unfolded with different concentrations of 
denaturant, different temperature or different pH. Since equilibrium unfolding involves 
thermodynamic measurements, it is essential that the unfolding reaction is allowed to reach 
equilibrium before measurements are taken and that the unfolding reaction is reversible (Pace 
et al., 1989). The equilibrium unfolding of a protein is often monitored using more than one 
technique such as circular dichroism and fluorescence spectroscopy as probes, which allows 
for the detection of changes in different aspects of the structure as a function of denaturation. 
An unfolding curve can then be constructed by plotting the collected data from different 
probes against different denaturant concentrations. Generally, an unfolding curve has a single 
or a multiple sigmoidal shape. 
 
Equilibrium unfolding curves can be analysed by fitting them to either a two-state or a 
multi-state-state model (Pace, 1986). A two-state mechanism is described as: 
N ↔ U 
where N and U represent the native and the unfolded species respectively, which are 
populated at equilibrium during unfolding. In this mechanism, the unfolding of a protein is 
assumed to occur in a single step without any equilibrium intermediates. If an unfolding 
curve does not show a single sigmoidal transition or if data monitored using different probes 
do not superimpose, especially in the transition region, the unfolding reaction does not fall 
into the two-state category (Pace et al., 1989), and the curve would be better fitted to a 
three-state or a multi-state model as follows:  
N ↔ I* ↔ U 
where I* represents one or more intermediate(s) populated at equilibrium.  
 
 
Mechanism (A) 
Mechanism (B) 
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From the analysis of an unfolding curve, two important thermodynamic parameters can be 
obtained: the free energy change in the absence of denaturant, (∆G(H2O)) and the m-value 
(Pace, 1986). The free energy change, ∆G, at any denaturant concentration shows a linear 
dependence on denaturant concentration. Therefore, ∆G(H2O) can be obtained using the 
linear extrapolation method (Greene and Pace, 1974) to track the ∆G back to zero denaturant 
concentration as shown in the following equation: 
∆G = ∆G(H2O) – m [denaturant] 
The free energy change in the absence of denaturant, ∆G(H2O), is an estimate of the 
conformational stability of the protein, i.e. how stable the native state of the protein is 
compared to the unfolded state (Pace, 1986). Comparing the conformational stability of 
proteins which have a slight difference in structure improves our understanding of the forces 
that stabilise the structure of the protein (Pace et al., 1989). For example, a mutated protein 
(even one which only involves a single amino acid mutation) may not be able to form a 
certain intramolecular hydrogen bond. The equilibrium unfolding study of this mutant will 
show reduced conformational stability when compared to the native protein. The importance 
of the mutated amino acid residue in the structural stability of the protein is thereby observed. 
In the same way, conformational stability studies can also be used to observe the influence of 
environmental conditions such as pH and temperature on the stability of a protein. The 
m-value obtained from equilibrium unfolding studies represents the dependence of ∆G on 
denaturant concentration. Moreover, the m-value has been shown to be proportional to the 
amount of the surface area exposed to the solvent during unfolding, under the assumption that 
denaturant binding sites are equally distributed on the protein surface (Myers et al., 1995).  
 
In addition to the thermodynamic information, equilibrium unfolding studies can also provide 
information about the unfolding and folding mechanism of a protein (Pace, 1986). If the 
equilibrium unfolding of a protein cannot fit to a two-state unfolding mechanism, this clearly 
(1) 
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indicates that the unfolding of that protein occurs in more than one step, that is, with the 
presence of intermediate(s). However, the observation of an unfolding transition without any 
detectable intermediates in the equilibrium unfolding studies does not definitively suggest 
that the protein unfolds in the absence of intermediate species. The observation only indicates 
that the intermediate states might not be stable enough to be detectable at equilibrium (Pace, 
1986). From this point of view, although equilibrium unfolding studies are able to provide 
some information about protein unfolding mechanisms, this experimental method has its 
limitations. Therefore, in order to understand the complete mechanisms of protein unfolding, 
the rate of unfolding of proteins is typically also investigated via kinetics studies. 
 
1.2.2. Unfolding kinetics and unfolding pathways 
A two-state transition as detected by equilibrium unfolding studies only indicates that no 
intermediate states are significantly populated at equilibrium or are detectable with the probes 
used (Pace, 1986). This method does not give any information about the occurrence of 
transient intermediate species. These are intermediate states that form rapidly from the native 
state and are then converted into the next intermediate structure or the unfolded state during a 
denaturation reaction. Since these intermediates are only transiently populated, they cannot 
be detected in equilibrium unfolding studies. As a result, unfolding kinetics analysis is 
required to detect these transient intermediates in the unfolding process and to further 
uncover the complete unfolding pathway of a protein (Jaenicke and Rudolph, 1989).  
 
Unfolding kinetics studies of a protein are often conducted by adding the protein into 
denaturant and monitoring the progress of the entire unfolding reaction. Therefore, these 
studies are able to monitor the kinetic events happening along the unfolding reaction and may 
detect those transient intermediates which do not populate at equilibrium. Similar to 
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equilibrium unfolding studies, unfolding kinetics is also often monitored using more than one 
technique as a probe. 
 
Two-state mechanism 
There are a few kinetic mechanisms which have been proposed (Utiyama and Baldwin, 1986). 
The simplest mechanism is a two-state mechanism as described in the following: 
N →U 
where N and U represent the kinetically populated native and unfolded species of the protein 
as unfolding progresses. If only two species are detectable at any time in unfolding, then only 
one kinetic phase will be detected, indicating that the unfolding is likely to occur in 
accordance with the two-state mechanism (Utiyama and Baldwin, 1986).  
 
Although a single kinetic phase often suggests a two-state unfolding mechanism, there are 
two exceptions suggesting the existence of intermediate species: differential results from 
different probes and the appearance of a burst phase. If the unfolding kinetics monitored by 
different probes exhibit variance, this indicates the existence of hidden intermediates even if 
the unfolding kinetics appears monophasic (Bhuyan and Udgaonkar, 1998). When one 
observes the kinetics of protein folding or unfolding using spectroscopic probes, the observed 
amplitude of a kinetic trace is sometimes smaller than the signal difference between the initial 
and final states as monitored at equilibrium. This phenomenon is called “burst phase”. In  
folding or unfolding kinetics studies, the appearance of burst phases often suggests that at 
least one additional kinetic phase exists before the kinetic events are able to be detected with 
the techniques used (Roder et al., 2000). Therefore, a burst phase is another indication of the 
existence of hidden intermediates where only one kinetic phase is apparent. Generally, burst 
phases occur due to the rapid accumulation of folding or unfolding intermediates in the early 
stages of protein unfolding (Roder et al., 2000).  
Mechanism (C) 
 15 
Sequential unfolding pathways with the appearance of intermediates 
If there are intermediates involved, the unfolding of a protein is naturally more complicated. 
When monitoring the unfolding kinetics of a protein, the appearance of more than one kinetic 
phase is a clear indication of the existence of species other than the folded native state and 
unfolded state (Utiyama and Baldwin, 1986). The unfolding pathways in the presence of 
intermediate species can be separated into two categories: sequential and parallel unfolding. 
In a sequential unfolding pathway, all the kinetic events occur in a sequence, that is, step by 
step. On the other hand, in a parallel unfolding pathway, the events occur in parallel, that is, 
at the same time. In the following, three three-state unfolding schemes are used as examples 
of sequential unfolding with an intermediate species: 
N → I →U 
 
N →U → I 
 
I ←N →U 
Since all three species are populated (N, I and U) during the unfolding process, two kinetic 
phases can be observed. Mechanism (D) represents an unfolding reaction via an on-pathway 
intermediate. Mechanisms (E) and (F) represent unfolding reactions with the involvement of 
an off-pathway intermediate. In the case of an on-pathway intermediate (mechanism D), all 
the native proteins need to pass through this intermediate state, and thus the formation of 
intermediate becomes a lag phase in the formation of the unfolded proteins (Bieri and 
Kiefhaber, 2000). In mechanism (E), the off-pathway intermediate is formed from U and does 
not lead N to U. To distinguish mechanism (D) and (E), interrupted unfolding experiments 
need to be performed (Bieri and Kiefhaber, 2000). From the results, the population of species 
can be calculated and plotted against time. Comparing the plots, the one without the expected 
lag phase in the formation of unfolded species indicates that the protein unfolds involving an 
Mechanism (D) 
Mechanism (F) 
Mechanism (E) 
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off-pathway intermediate. In mechanism (F), since an intermediate state is often less stable 
than the native state, it is likely to unfold faster than the native state and is thus difficult to 
isolate kinetically from the unfolded state under native conditions (Bai, 2003). Therefore, the 
unfolding reaction described by scheme (F) is generally unlikely to occur under native 
conditions or will only occur under a specific condition that stabilises the formation of the 
off-pathway intermediate. 
 
Parallel unfolding pathways 
Despite the sequential unfolding schemes mentioned above, it is also possible for unfolding 
to occur via a parallel pathway. The parallel unfolding can be described in the following 
representative schemes:  
 
 
  
                                   
 
 
In scheme (G), the reaction starts with two groups of native species unfolding at the same 
time to the unfolded state via a parallel pathway. The parallel pathway results from the fact 
that the native state consists of two slowly interconverting forms with a slight difference such 
as a cis- and trans-proline, and the unfolding reaction is faster than the interconverison 
(Wallace and Matthews, 2002). As with the sequential mechanisms, there are also two kinetic 
phases observed in this scheme. The number of kinetic phases detected will represent the 
species appearing in the unfolding reaction but it cannot tell whether the unfolding reaction 
proceeds via a sequential or a parallel pathway. A method called the initial conditions test 
(ICT) is, therefore, required to distinguish whether the observed biphasic unfolding occurs 
U 
N  
N 
N U 
I 
Mechanism (G) 
Mechanism (H) 
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via a sequential or a parallel pathway (Wallace and Matthews, 2002). The method relies on 
the fact that the rate of unfolding of a protein depends only on the final denaturant 
concentrations while the amplitude of the observed kinetic phase is dependent on both the 
initial and final denaturant concentrations (Tanford, 1970; Hagerman and Baldwin, 1976). In 
mechanism (H), a protein unfolds through two independent pathways: one directly from the 
native state to the unfolded state and one from the native state through an intermediate state 
to the unfolded state. Since there are also three species populated during the unfolding 
process, two kinetic phases can be observed and this mechanism cannot be distinguished 
from mechanism (E) easily. However, when performing a least-squares fit to the 
denaturant-dependence of the two apparent rate constants, only a triangular model can be 
used to explain the data obtained from mechanism (H) (Wildegger and Kiefhaber, 1997). 
 
The rate-limiting step in the unfolding reaction 
There are two common rate-limiting steps in a protein unfolding process. The first one is 
proline cis-trans isomerisation of peptides bonds. The configuration of peptide bonds in a 
protein molecule can be either in the cis- or trans- form. However, the cis conformation is 
strongly disfavoured in non-proline dipeptides. The instability of the cis-form in non-proline 
dipeptides results from the steric hindrance between the two α-carbon atoms (Zimmerman 
and Scheraga, 1976). On the other hand, the cis-form of an Xaa-Pro dipeptide is relatively 
stable. A representative unfolding mechanism which involves proline cis-trans isomerisation 
can be described as follows: 
N →Uf ↔ Us 
where Uf represents a single unfolded population with native prolyl isomers and Us represents 
one or more unfolded species of non-native isomers. In this mechanism, the unfolded form Uf 
is formed in the N ↔ Uf transition and Us is then formed from Uf. These two unfolded forms 
are both populated when the protein is completely unfolded. This phenomenon was first 
Mechanism (I) 
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discovered by Garel and Baldwin in unfolded RNase A which consists of a heterogeneous 
mixture of unfolded molecules (Garel and Baldwin, 1973). Later on, Brandts and co-workers 
explained that the transition between the two unfolded forms is caused by proline cis-trans 
isomerisation in the protein molecule (Brandts et al., 1975). Proline isomerisation is a slow 
reaction because it involves rotation about the whole peptide bond. Therefore, proline 
isomerisation results in a slow step not only in protein unfolding but also in protein folding. 
 
In addition to proline isomerisation, the reduction of intramolecular disulfide bonds can also 
be a rate-limiting step in protein unfolding and folding (Creighton, 2000). The disulfide bond 
is a covalent bond formed between the thiol groups of two cysteine residues. Since disulfide 
bonds stabilise the structure of proteins, they need to be reduced before the unfolding reaction 
can proceed further. The formation of disulfide bonds can also be rate-limiting in the protein 
folding process in vivo. The concentration of thiolate anions and the accessibility, proximity, 
and reactivity of the thiol group and disulfide bonds are the four main factors which influence 
disulfide bond formation (reviewed by Mamathambika and Bardwell, 2008). The rate of 
thiol-disulfide exchange strongly depends on the concentration ratio of the reactive thiolate 
anions and the unreactive thiol groups (reviewed by Mamathambika and Bardwell, 2008). 
The pKa of cysteine residues in unfolded proteins is about 8.7. Therefore, the ideal pH for 
formation of disulfide bonds is above 9 where most species will be the reactive thiolate 
anions. Below this pH, the reaction will become progressively slower due to the decrease of 
the amount of the thiolate anions. In cells, the physiological pH is about 7.4 promoting slow 
formation of disulfide bonds. In order to solve this problem, organisms use disulfide 
oxidoreductase to decrease the pKa of the thiol groups and thus the thiol group can remain 
ionised and reactive at physiological pH (reviewed by Mamathambika and Bardwell, 2008). 
Moreover, because a disulfide bond forms between two cysteine residues, the number of free 
cysteine residues present and available for exchange also influences on the formation of 
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disulfide bonds and further affects the folding rate of proteins. The location of disulfide bonds 
also has an effect on the rate of protein unfolding. Generally, if the disulfide bonds are in or 
close to the folding nucleus, the protein folding will be accelerated (Abkevich and 
Shakhnovich, 2000). In contrast, disulfide bonds far from the folding nucleus often decelerate 
the folding of proteins. 
 
Unfolding of oligomeric proteins 
There are two prerequisites for all the unfolding schemes discussed above: the protein must 
be monomeric and the unfolding reaction must be reversible. For oligomeric proteins, over 
and above the general unfolding reaction discussed above, the disassociation of the subunits 
is also involved in the unfolding process (Jaenicke and Rudolph, 1989). For example, the 
overall unfolding pathway of a dimeric protein generally begins with a folded dimer (N2) and 
ends with two unfolded polypeptide chains (2U) (Rumfeldt et al., 2008). A few of the 
possible mechanisms are given in the following (Walters et al., 2009): 
N2 →  2U 
 
N2 →  I2 →  2U 
 
N2 →  2N →  2U 
 
N2 →  2I →  2U 
The unfolding can simply follow a two-state pathway as shown in mechanism (J). If there are 
more species than the native state (N2) and the unfolded state (2U) involved in the unfolding 
reaction, the pathway can be described in mechanisms (K) to (M). In mechanism (K), the 
intermediate is a dimeric intermediate, I2. If disassembly of two monomeric subunits happens 
prior to unfolding, the pathways are described in mechanisms (L) and (M). In these two 
Mechanism (K) 
Mechanism (L) 
Mechanism (M) 
Mechanism (J) 
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mechanisms, the intermediate state is either two native monomers (2N) or two monomeric 
intermediates (2I) (Walters et al., 2009) 
 
Irreversible unfolding 
Not all protein unfolding processes are reversible. Irreversibility of unfolding reactions is a 
common problem in protein unfolding studies. A common sign of the irreversible unfolding 
process of a protein is the formation of aggregates (Eftink and Maity, 2000). The other 
indications include the inability to recover either the biological activity or physical properties 
of the native protein when the denaturing conditions are removed. The simplest 
representative irreversible unfolding pathway can be written as follows: 
N ↔ U → D 
where D represents a permanent denatured state. The example here is just one of the possible 
aggregation pathways. As demonstrated in Figure 2, it is possible for a protein to form 
aggregates from any structural state. In kinetics studies, since the whole progression in the 
transition (such as a N →U transition) is monitored prior to the aggregation process (U to D), 
the events that occur along the unfolding pathway can still be detected. However, in 
equilibrium unfolding, the irreversible process will influence the shape of the transition and 
thus lead to unreliable thermodynamic data (Lepcock et al., 1992). Equilibrium unfolding 
studies are thus unable to be performed on this kind of protein. 
 
1.3. Metamorphic proteins 
It was previously thought that proteins adopt their unique three-dimensional conformations 
under native physiological conditions (Anfinsen, 1973). However, more and more studies 
have demonstrated that some proteins have more than one native tertiary structure. These 
proteins are called metamorphic proteins (Murzin, 2008). Metamorphic proteins switch 
Mechanism (N) 
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between different native structures to conduct their complete functions. For the conversion 
between different native conformations of metamorphic proteins, unfolding of the original 
structures and refolding to the new configuration are essential. These structural transitions 
often involve secondary structural content change, appearance of new exposed surface and 
protein hydrophobic core repacking (Bryan and Orban, 2010). Examples of these proteins 
include serine protease inhibitor (Mottonen et al., 1992), influenza virus hemagglutinin 
(Bullough et al., 1994), lymphotactin (Tuinstra et al., 2008), Mad2 spindle checkpoint protein 
(Luo et al., 2004) and the chloride intracellular channel family (Littler et al., 2004). 
 
Although many different types of proteins are included in the metamorphic protein category, 
there are three common features needed for structural transition (Bryan and Orban, 2010). 
First, reduced conformational stability of proteins is necessary for fold switching. Since the 
native structures of proteins are known as the most stable, their location in terms of free 
energy is at the minimum of the energy landscape. Therefore, it is difficult for proteins in 
their native states to transform to a new ordered state. However, if the native state of a protein 
has a reduced conformational stability, that is, a more flexible structure, then this flexible 
structure is able to lower the energy barrier required for fold switching between the native 
state and the new ordered state and thus makes it easier for the protein to transit into the new 
conformation. Second, flexible regions are required to facilitate the configurational transition. 
New exposed surfaces are the last feature in protein fold switching. Sometimes these new 
surface areas stabilise the new alternative states through forming stable oligomeric 
conformations or else enable the proteins to interact with other biological molecules such as 
membranes and consequently form new conformations. The formation of these oligomers and 
new structures often lead the proteins to a new biological function. 
 
 
 22 
1.4. Soluble proteins that insert into membranes 
Typical membrane proteins are synthesised on ribosomes and inserted into the membrane 
co-translationally (reviewed by Shao and Hegde, 2010). There are, however, certain proteins 
with a property distinct from typical membrane proteins in that they are expressed as soluble 
proteins without a leader sequence for membrane targeting, but are able to insert into or 
associate with membranes subsequently. Because these proteins exist in both soluble and 
membrane-bound forms, they conform to the definition of existing in more than one native 
conformation and are, therefore, also classified as metamorphic proteins. These proteins 
include some bacterial toxins (Parker and Feil, 2005), porins (Parker and Pattus, 1993), the 
eukaryotic proteins Bcl-2 (Schendel et al., 1997; Thuduppathy and Hill, 2005; Thuduppathy 
et al., 2006), Bax (García-Sáez et al., 2004) and the CLIC family (Ashley, 2003). Several of 
these proteins function as channels after membrane insertion, indicating that they not only 
associate with the membrane but must also completely cross the lipid bilayer and form a pore. 
The most interesting question about these proteins is how they change from one native state 
to the other. 
 
The insertion mechanisms for some of these special proteins, such as bacterial pore-forming 
toxin colicin A and colicin E1, have been uncovered (Zakharov and Cramer, 2002). The polar 
heads of the lipid molecules which constitute biological membranes are highly negatively 
charged. Therefore, the negatively charged membrane surface attracts hydrogen ions and thus 
causes the local environment to become acidic (McLaughlin, 1989). The hydrogen ions at the 
membrane surface protonate the acidic residues on the surface of colicin and further increase 
the hydrophobicity of the protein. This reduces the activation energy barrier to conversion 
between soluble and membrane-bound states. The insertion of colicin also involves the 
formation of a molten globule-like intermediate induced by low pH at the membrane surface. 
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As mentioned in section 1.1.1., the molten globule state has a significant amount of exposed 
hydrophobic surface. Therefore, the increase in protein hydrophobicity either by protonation 
at the membrane surface or by formation of a molten globule-like intermediate facilitates the 
insertion of soluble proteins into highly hydrophobic membranes.  
 
1.5. Chloride intracellular channels 
The chloride intracellular channel (CLIC) family is a group of putative channel proteins 
which have different structural properties to the other known classes of channel proteins. This 
family consists of six members (CLIC1-6) in vertebrates (reviewed by Littler et al., 2010 and 
Singh, 2010). The CLIC homologues have also been identified in plants (Elter et al., 2007) 
and in invertebrates (DmCLIC in Drosophila melanogaster, and CLIC-like proteins EXC-4 
and EXL1 in Caenorhabditis elegans) (Berry et al., 2003; Littler et al., 2008). A highly 
conserved carboxyl-terminal core segment about 240 amino acid residues long is the 
signature of this family. CLICs share both sequence and structural homology with the 
glutathione S-transferase (GST) proteins and thus CLICs belong to the GST superfamily 
(Dulhunty et al., 2001; Harrop et al., 2001).  
 
Although the exact physiological function for CLIC proteins is still uncertain, the high 
sequence conservation of the CLICs in vertebrates suggests their functional importance. 
CLICs have been shown to be involved in various biological processes, including cellular 
division (Valenzuela et al., 1997; Berryman and Goldenring, 2003), bone resorption 
(Schlesinger et al., 1997), cell cycle regulation (Valenzuela et al., 2000), p53-mediated 
apoptosis (Fernandez-Salas et al., 1999 and 2002; Suh et al., 2004 and 2005), kidney function 
(Berry et al., 2003), and cancer-related processes such as cellular differentiation (Suh et al., 
2007), tubulogenesis (Berry et al., 2003) and angiogenesis (Tung et al., 2009; Tung and 
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Kitajewski, 2010). CLICs have also been implicated in Alzheimer’s disease (Novarino et al., 
2004; Milton et al., 2008). 
 
1.6. Overview of CLIC1 
CLIC1, previously called NCC27 (nuclear chloride channel 27), has been the most widely 
studied of the CLIC family. This protein is distributed in diverse cells and tissues (Ulmasov et 
al., 2007) and is reported to form functional ion channels in the plasma and nuclear 
membranes of cells (Tulk et al., 2000; Warton et al., 2002). Although previous studies have 
shown that the expression of CLIC1 results in increased chloride channel activity in cultured 
cells (Valenzuela et al., 1997; Tonini et al., 2000), subsequent experiments have suggested 
that the CLIC1 channel is not only for chloride ions but also for a wider range of anions 
(Valenzuela et al., 1997; Singh and Ashley, 2006). The anion selectivity of CLIC1 channels is 
thus poor and the conductance is dependent on anion concentration (Singh and Ashley, 2006; 
Singh et al., 2007). In the following section, in order to get an insight into the CLIC1 
insertion mechanism, the structure and auto-insertion controls of CLIC1 will be introduced. 
 
1.6.1. Structure of soluble CLIC1 
1.6.1.1. Primary sequence and secondary structure 
CLIC1 consists of 241 amino acid residues which give it a theoretical molecular weight of 
26.9 kDa and a pI of 4.85 (Valenzuela et al., 1997; Ashley, 2003). The primary sequence and 
secondary structure are indicated in Figure 3. The CLIC1 monomer contains 10 α-helices and 
four β-strands, resulting in 47.7% α-helices and 8.3% β-strands in the secondary structure of 
CLIC1 according to the crystal structure (Harrop et al., 2001). In CLIC1, there is only one 
tryptophan, Trp35 (Figure 3). Eight tyrosine and six cysteine residues are distributed 
throughout the protein molecule.  
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Figure 3: Amino acid sequence and secondary structural elements of CLIC1 
The red bars and green arrows represent α-helices and β-strands beta strands, respectively 
(Harrop et al., 2001). The lone tryptophan is indicated by red circle. This figure was 
generated using the sequence of CLIC1 obtained from NCBI using the accession code 
CAG46868.1. 
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1.6.1.2. Tertiary structure 
The x-ray crystallographic structure of the soluble form of CLIC1 determined at a resolution 
of 1.4 Å (Harrop et al., 2001) is shown in Figure 4. Soluble, reduced CLIC1 is monomeric, 
consisting of two domains: the N- and C-domains. The N-domain (residues 1-90) possesses a 
thioredoxin fold which contains a redox-active site similar to glutaredoxin. The lone 
tryptophan is located in this domain (Figure 4). There is a proline-rich loop (Cys89-Asn100) 
connecting the N- and C-domains. This proline-rich domain-connecting loop is the origin of 
domain interface plasticity in the structure (Harrop et al., 2001). Moreover, since the 
N-domain is proposed to detach from the C-domain to initiate membrane insertion of CLIC1, 
the loop which leads to flexibility between the two domains is likely to be involved in the 
transition between the soluble and the transmembrane forms of CLIC1 (Harrop et al., 2001).  
 
The all-helical C-domain closely resembles that of Omega GST, but there are two distinct 
differences: the position of the carboxyl-terminal helix α9 and the existence of an acidic loop 
region (Pro147-Gln164) (Harrop et al., 2001). This loop locates between helices α5 and α6 
and consists of seven acidic residues. These acidic residues result in a highly negative net 
charge of -7 for CLIC1. Since this negatively charged loop is flexible and structurally close to 
the proline-rich loop connecting the two domains, it is assumed to play a role in 
protein-protein interactions (Harrop et al., 2001). 
 
 
 
 
 
 
 27 
 
 
 
Figure 4: Crystal structure of soluble reduced CLIC1 
The N-domain containing the thioredoxin fold is indicated in orange and blue. The all 
α-helical C-domain is shown in green and yellow. The putative transmembrane region is in 
blue. The proline-rich loop linking the two domains is shown in pink and the negatively 
charged loop is indicated in yellow. The lone tryptophan residue, Trp35 is shown in red and 
the eight tyrosine residues (two in the N-domain, six in the C-domain) are indicated in black. 
The cysteine residue (Cys24) located in the GSH binding site is shown in purple. This figure 
was generated using PyMOL™ (DeLano Scientific, 2006) using the PDB file 1K0M (Harrop 
et al., 2001). 
55Å 
52Å 
23Å 
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Redox effects on CLIC1 
The N-domain of CLIC1 contains a glutathione (GSH) binding site. The center of the active 
site is a redox-active cysteine (Cys24), which is located at the beginning of helix α2 in the 
N-domain (Harrop et al., 2001). CLIC1 can form both non-covalent and covalent interactions 
with GSH, however, CLIC1 does not bind to a GSH-Sepharose matrix. Also, GSH binding 
studies of CLIC1 using isothermal titration calorimetry cannot detect any noncovalent GSH 
binding below 10 mM GSH, which is in contrast with the strong binding between GSH and 
GSTs (Wilce and Parker, 1994). Therefore, non-covalent interactions between CLIC1 and 
GSH appear to be weak. In contrast, Cys24 forms a strong covalent interaction with GSH via 
a mixed disulfide bond under certain oxidising conditions (Harrop et al., 2001). It has been 
suggested that CLIC1 may use its GSH-binding site to recognise the mixed disulfide bond of 
some GSH-modified proteins which may thus target the chloride channel to a specific 
subcellular location (Harrop et al., 2001). Moreover, the mechanism for opening and closing 
the CLIC1 channels once inserted into membranes is also related to the redox condition 
(Singh and Ashley, 2006). In fact, the redox condition has been thought to be a control for 
membrane insertion of CLIC1. This will be discussed later on.  
 
Putative transmembrane domain 
The region from Cys24 to Val46 has been identified as the putative transmembrane domain 
(PTMD) for CLIC1 (Duncan et al., 1997; Valenzuela et al., 1997; Edwards, 1999; 
Fernandez-Salas et al., 1999; Qian et al., 1999; Berryman and Bretscher, 2000). The PTMD 
consists of helix α1 and strand β2 in the N-domain. In the PTMD of CLIC1, there are two 
conserved phenylalanines (Phe26 and Phe41). Ten non-polar residues (Leu30 to Val39) are 
located between these two conserved phenylalanine residues. The remaining places are filled 
in with six to seven polar residues. This sequence of the PTMD matches a typical pattern for 
transmembrane helices (Sakai and Tsukihara, 1998). The non-polar residues in the PTMD 
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form a hydrophobic surface patch exposed on one side of the protein molecule (Harrop et al., 
2001). This surface in the proteins that are closely related to the CLICs in terms of sequence 
similarity contains several additional charged residues and thus is not hydrophobic. Therefore, 
the hydrophobicity of helix α1 and strand β2 makes CLIC1 unique in the GST superfamily 
(Harrop et al., 2001). It is hypothesised that the transmembrane region detaches from the 
C-domain, unfolds, and refolds into its membrane-bound conformation (Fanucchi et al., 
2008). However, the exact mechanism of this process as well as the role that the C-terminal 
domain plays in this process is still unknown. 
 
1.6.2. The factors influencing CLIC1 membrane-insertion in vitro 
The mechanism of CLIC1 membrane-insertion remains unknown. However, previous studies 
have proposed some factors which are able to influence CLIC1 insertion in vitro. These 
factors include pH and redox status. 
 
1.6.2.1. Redox condition 
It has been shown that the insertion of CLIC1 into membranes is under redox control (Singh 
and Ashley, 2006; Goodchild et al., 2009; Littler et al., 2004 and 2010). Under oxidising 
conditions, insertion and channel activity of CLIC1 are enhanced in artificial membranes. 
Cys24 is involved in this reaction. Although the CLIC1 C24A mutant is still able to insert 
into membranes, the redox control of insertion is removed (Singh and Ashley, 2006). Upon 
oxidation, it has been shown that CLIC1 forms a reversible non-covalent dimer with an 
intramolecular disulfide bond between Cys24 and Cys59 (Figure 5) (Littler et al., 2004). 
Dimeric CLIC1 undergoes a dramatic structural rearrangement when compared to monomeric 
CLIC1. Instead of the four β-strands, α-helices and loops emerge in the N-domain and form a 
hydrophobic dimer interface non-covalently interacting with the other subunit of the CLIC1 
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Figure 5: Structure of dimeric oxidised CLIC1 
Upon oxidation, CLIC1 undergoes a dramatic structural transition to form a homodimer. In 
this dimeric structure, an intramolecular disulfide bond forms between Cys24 (yellow) and 
Cys59 (orange). The all-helical C-domain (blue) retains the original structure whereas the 
N-domain (cyan) rearranges from three α-helices and four β-strands to an all α-helical 
structure. This figure is generated by PyMOL™ (DeLano Scientific, 2006) using PDB entry 
1RK4 (Littler et al., 2004). 
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dimer (Figure 5). It is proposed that CLIC1 might use a structure similar to this hydrophobic 
dimer interface to dock it on the membranes (Littler et al., 2010). However, it has been 
demonstrated that both monomeric and dimeric CLIC1 have the ability to insert into and form 
functional ion channels in artificial membranes (Littler et al., 2004). Moreover, oxidation of 
monomer promotes insertion better than oxidation of dimer (Goodchild et al., 2009). 
Therefore, the CLIC1 dimerisation process is not necessary for membrane docking and 
insertion (Goodchild et al., 2009). Furthermore, the discrete dimer formed by the strong 
interaction between the hydrophobic interfaces may even cause steric hinderance for CLIC1 
in terms of membrane docking and insertion (Goodchild et al., 2009). In addition, Cys59 is 
not conserved in other CLICs and thus it is difficult to conclude the role of the intramolecular 
disulfide bond in membrane insertion of the CLIC family. 
 
1.6.2.2. The effect of pH 
CLIC1 channel formation and activity have been reported to be highly pH-dependent (Tulk et 
al., 2002; Warton et al., 2002). The activity at neutral pH is lowest while it rises at both 
acidic and basic pH (Tulk et al., 2002; Warton et al., 2002). It has been demonstrated that, in 
the absence of denaturant or membranes, the core structure and size of CLIC1 do not show 
any significant changes at different pH values (Fanucchi et al., 2008). However, 
hydrogen-deuterium exchange studies do show that the PTMD in the N-domain is more 
flexible at acidic pH than at neutral pH (Stoychev et al., 2009). Equilibrium unfolding studies 
of CLIC1 show a two- and three-state transition at pH 7.0 and pH 5.5, respectively. A stable 
equilibrium intermediate forms in the presence of mild urea concentrations at pH 5.5 
(Fanucchi et al., 2008), which corresponds roughly to the pH value at the surface of 
membranes (McLaughlin, 1989), and the intermediate does not appear at pH 7.0 (roughly the 
pH value in cytosol). This equilibrium intermediate retains approximately 50% of the native 
secondary structure and has a well-packed tertiary structure similar to the native CLIC1 
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(Fanucchi et al., 2008). Despite overall similar tertiary structure, the lone CLIC1 tryptophan 
residue which is located in the PTMD becomes more buried in the intermediate state 
compared to the native state (Fanucchi et al., 2008). The hydrophobic fluorescent dye ANS 
binds to the intermediate more strongly than to the native and unfolded states, indicating that 
the intermediate has more hydrophobic surfaces exposed than the native and unfolded states 
(Fanucchi et al., 2008). As proposed by Littler et al. (2010), the membrane-docking form of 
CLIC1 is likely to possess exposed hydrophobic surfaces in order to interact with membranes. 
Therefore, this equilibrium intermediate which has exposed hydrophobic areas may be 
significant in CLIC1 membrane-docking.  
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1.7. Objective 
Since it has been suggested that CLIC1 needs to unfold partially prior to membrane insertion, 
the main objective of this study is to determine the unfolding mechanism of CLIC1. This 
objective can be divided into three aims.  
 
Aims: 
1. Characterise the structure of CLIC1 under different pH values corresponding to the pH in 
cytosol and at the membrane surface (pH 7.0 and pH 5.5, respectively) and different urea 
concentrations where the native, intermediate, and unfolded states of CLIC1 are 
populated.  
 
2. Perform equilibrium unfolding studies to detect the conformational stability of CLIC1 at 
pH 7.0 and pH 5.5 to investigate the influence of pH on the stability of the protein. CLIC1 
has been shown to form a stable equilibrium intermediate under mild denaturing 
conditions at pH 5.5 (Fanucchi et al., 2008). This intermediate has structural properties 
that are similar to the proposed CLIC1 membrane-docking form. Therefore, the exact 
conditions at which the intermediate state is stable need to be determined for the 
subsequent kinetic experiments.  
 
3. Measure the unfolding kinetics of CLIC1 from the native state to the unfolded state 
(N →U), from the native state to the intermediate state (N → I), and from the intermediate 
state to the unfolded state (I →U) at pH 7.0 and pH 5.5. This aim forms the largest part of 
this study. Unfolding kinetics studies have never been done before on CLIC1. First, 
unfolding of N →U will be measured at both pH 7.0 and pH 5.5 in order to compare the 
different unfolding behaviours of CLIC1 in the environments which are similar to the 
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cytosol and membrane surface. Since the equilibrium intermediate only appears at pH 5.5, 
the unfolding of the N → I and I →U transitions will only be monitored at this pH. The 
most important part of this study is to observe the kinetic mechanism of the formation of 
the equilibrium intermediate. This novel study has the potential to improve the knowledge 
of the membrane insertion mechanism of CLIC1. 
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2. Experimental procedures 
2.1. Materials 
The pGEX-4T-1 plasmid encoding the cDNA for recombinant GST-CLIC1 fusion protein 
was a gift from S. N. Breit, Centre for Immunology, St. Vincent’s Hospital and University of 
New South Wales, Sydney, Australia. Isopropyl-β-D-thiogalactopyranoside (IPTG) and 
dithiothreitol (DTT) were obtained from Melford Laboratories Ltd (Suffolk, UK). Thrombin 
from human plasma (1 KU) was purchased from Sigma-Aldrich (St. Louis, MO, USA). 
Reduced glutathione (GSH), 8-anilino-1-naphthalene sulfonate (ANS) and ultrapure urea 
were acquired from Merck laboratory supplies (Darmstadt, Germany). SDS-PAGE molecular 
weight markers were purchased from Fermentas (Ontario, Canada). All the other chemicals 
used in this study were of standard analytical grade. 
 
2.2. Methods 
2.2.1. Expression and purification of recombinant CLIC1 
Expression 
CLIC1 was expressed and purified following the methods used by Fanucchi et al. (2008) with 
a few modifications. First of all, Escherichia coli BL21(DE3) pLysS cells were transformed 
with the pGEX-4T-1 plasmid containing the GST-CLIC1 fusion protein. A glycerol stock was 
prepared by adding transformed E. coli cells at mid-log phase to sterile glycerol in a 1 : 1 
ratio and stored at -80˚C. Two hundred microlitres of BL21 cells from the glycerol stock were 
added into a sterile 200 ml 2X YT medium (1.6% tryptone, 1% yeast extract and 0.5% NaCl). 
All the sterile media were inoculated with 100 µg/ml ampicillin before use. The cells were 
then incubated overnight at 37˚C with shaking at 250 rpm. The next day, each overnight 
culture was poured into a 2L sterile 2X YT medium and incubated at 37˚C with shaking at 
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250 rpm for approximately 2.5 hours until the OD600 reached 0.6 ~ 0.8. The overexpression of 
the fusion protein was induced by adding IPTG to a final concentration of 1 mM and the cells 
were allowed to grow for another 4 ~ 5 hours. The cells were then centrifuged at 5000 rpm 
for 15 minutes at 5 ~ 20˚C in a Sorvall RC5C centrifuge using a SLA3000 rotor. The pellet 
was resuspended in 3 ml resuspension buffer, pH 8.0 (10 mM Tris-HCl, 100 mM NaCl,     
1 mM EDTA, 0.02% NaN3) and stored at -20˚C. 
 
The frozen cells were defrosted with rotating at 4˚C. After thawing, 50 µl DNase (0.1 g/ml), 
500 µl MgCl2 (0.095 g/ml) and 250 µl lysozyme (0.1 g/ml) were added to each 25 ml cell 
solution and mixed properly. The cells were then sonicated on ice for 5 cycles of 30 seconds, 
pulsed (intensity 4, pulsed 0.5 sec) on a Sonicator™ Ultrasonic Processor XL (Misonix Inc.). 
The lysed cells were centrifuged at 15 000 rpm, for 30 minutes, at 4 ~15˚C using a SS34 rotor 
and the supernatant was collected. 
 
Glutathione-Sepharose affinity chromatography 
Before use, a 10 ml GSH-Sepharose column was equilibrated at 4˚C with 150 ~ 200 ml 
GSH-equilibration buffer, pH 8.0 (10 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1 mM 
DTT added fresh). The supernatant obtained from the lysed cells was diluted 5X with 
GSH-equilibration buffer and loaded onto the GSH-Sepharose column. This method is based 
on the strong affinity between CLIC1-fused GST and GSH. The GST-CLIC1 fusion protein 
can thus be retained in the column and separated from the contaminating proteins in the 
supernatant. To improve the quantity of bound GST-CLIC1 fusion protein to the resin of the 
GSH-Sepharose column, the flow-through was collected and reloaded. After the supernatant 
was reloaded, the column was washed with 300 ml GSH-equilibration buffer in order to wash 
off all the unbound fusion protein and contaminants. Then the column was equilibrated with 
five column volumes of thrombin cleavage buffer, pH 8.4 (200 mM Tris-HCl, 1.5 M NaCl, 
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25 mM CaCl2, 0.8 mM DTT added fresh). To separate CLIC1 from resin-bound GST, two 
column volumes of thrombin cleavage buffer containing human plasma thrombin (80 µl per 
litre cell culture) was loaded on the column. The cleavage reaction was allowed to continue 
for 16 hours at 20˚C on a rotator. The next day, after digestion, the GSH-Sepharose resin was 
allowed to settle before the CLIC1 and thrombin mixture was collected. 
 
Anion-exchange chromatography 
A 40 ml DEAE-Sepharose column was equilibrated with 400 ml DEAE-equilibration buffer, 
pH 6.5 (20 mM Tris-HCl, 0.02% NaN3) before use. DEAE is a positively charged group 
covalently linked to the Sepharose beads and has the ability to bind and retain negatively 
charged particles. Increasing the ionic strength or varying the pH value of the elution buffer 
are common methods used to elute bound particles. CLIC1 and thrombin are able to be 
separated due to the difference in their pI values. At pH 6.5, human thrombin with a pI value 
of 7.0 ~ 7.6 (Fenton et al., 1977) is positively charged and does not bind to the DEAE resin 
whilst CLIC1 with a pI value of 4.85 (Ashley, 2003) becomes negatively charged and binds 
to the resin. The solution containing CLIC1 and thrombin from the GSH-Sepharose column 
was loaded onto the DEAE-Sepharose column and the column was washed with 150 ml 
DEAE-equilibration buffer to ensure that all the thrombin was removed. CLIC1 was then 
eluted with an increased salt concentration (DEAE-equilibration buffer containing 300 mM 
NaCl) and the fractions were collected for every 3 ml. The high concentration of salt results 
in an enhanced competition between the anions in the buffer and the negatively charged 
CLIC1 for the positively charged DEAE groups on the resin, and hence it reduces the 
interaction between the resin and CLIC1 molecules, and thus causes the protein to elute. 
CLIC1 was successfully eluted between 30 ml and 60 ml. 
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2.2.2. Confirmation of protein purity 
SDS-PAGE is a technique used to separate and characterise complex mixtures of proteins 
(reviewed by Makowski and Ramsby, 1997). The basic principle for the method is that 
charged particles in an electric field move toward the electrode of opposite sign. SDS is an 
anionic detergent that is able to denature secondary and non-disulfide linked tertiary 
structures of proteins. SDS generally binds to protein molecules in a ratio of 1.4 g/g protein. 
Since the negative charge of the bound SDS is large, it has ability to mask the net charge of 
the protein effectively, giving all the proteins in the sample a uniform charge:mass ratio. 
Therefore, the coated negative charge is in proportion to the mass of the protein molecule so 
that the distance of migration of the protein through the gel is only related to the size of the 
protein (reviewed by Makowski and Ramsby, 1997). The different proteins in the sample are 
thus able to be separated according to their size. 
 
In this study, the discontinuous system (Laemmli, 1970) was used for SDS-PAGE analysis. 
Discontinuous systems divide the gel into two parts: an upper part called the stacking gel 
with large pore size and low pH (pH 6.8) and a lower part called the resolving gel with 
smaller pores and higher pH (pH 8.8). The electrode buffer contains glycine anions while 
both gels use chloride ions as the main mobile anions. In the stacking gel with a pH value of 
6.8, glycines are mainly zwitterions without net charge and thus move very slowly in the 
electric field. On the other hand, the strongly charged, smaller chloride ions move relatively 
faster in the electric field and cause the formation of an ion front. The faster-moving chloride 
ions followed by the slower-moving glycine zwitterions result in two separated fronts of 
migrating ions and thus creates a narrow zone between the two fronts. All the proteins in the 
gel have an intermediate mobility between the glycine and chloride ions. Therefore, when the 
two fronts pass through the sample wells, the proteins will be concentrated in the narrow zone 
 39 
between the chloride and glycine ion fronts. When the glycine front reaches the running gel 
which has a pH of 8.8, the increase in pH makes the glycine molecules ionised and then 
increases their mobility. The proteins are, therefore, left behind and stack in the narrow band 
at the interface between the stacking and running gels. The function of the protein stacking is 
to improve band sharpness and resolution. The proteins are now allowed to separate 
according to the difference in their molecular weight in the resolving gel. 
 
For all SDS-PAGE experiments in this study, the stacking gels (4%) used were composed of 
1.3 ml 30% acrylamide/bis (acrylamide : bis = 37.5 : 1), 2.5 ml 0.5 M Tris-HCl, pH 6.8,   
0.1 ml 10% SDS, 50 µl 10% ammonium persulfate, 10 µl TEMED and 6.1 ml dH2O. The 
separating gels (15%) used consisted of 5 ml 30% acrylamide/bis (acrylamide : bis = 37.5 : 1), 
2.5 ml 1.5 M Tris-HCl, pH 8.8, 0.1 ml 10% SDS, 50 µl 10% ammonium persulphate, 5 µl 
TEMED and 2.4 ml dH2O. Sample buffer was composed of 0.5 ml 2% bromophenol blue,  
2.5 ml 0.5 M Tris-HCl (pH 6.8), 8 ml 100% glycerol, 4 ml 10% SDS, 1 ml 2-mercaptoethanol 
and 3.5 ml dH2O and was added to each sample in a 1:1 sample buffer to sample ratio. 
Samples were then boiled for 5 minutes and 10 ~ 15 µl of each sample was loaded on the gels. 
The electrode buffer, pH 8.3, consists of 14.4% glycine, 3% Tris-HCl and 1% SDS in 1 L. 
The electrophoresis was performed at 200 V until the dye front reached 0.5 cm from the 
bottom of the gels. The gels were stained for 2~16 hours in Coomassie Blue stain solution 
made up of 0.25% (w/v) Coomassie Brilliant Blue R250, 45% (v/v) methanol and 10% (v/v) 
glacial acetic acid. Then gels were destained in the destain solution consisting of 25% (v/v) 
ethanol and 10% (v/v) glacial acetic acid for 3 ~ 16 hours. 
 
In this study, samples for the gels included the protein complement of Escherichia coli cells 
before and after induction with IPTG, the pellet and supernatant of the lysed cells, the 
flow-through from the GSH-Sepharose column, the CLIC1-thrombin mixture from thrombin 
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cleavage, thrombin separated from the CLIC1 and thrombin mixing solution, cleaved GST 
and purified CLIC1. The molecular mass markers used were β-galactosidase (116 kDa), 
bovine serum albumin (66.2 kDa), ovalbumin (45 kDa), lactate dehydrogenase (35 kDa), 
restriction endonuclease Bsp981 (25 kDa), β-lactoglobulin (18.4 kDa) and lysozyme    
(14.4 kDa). 
 
After confirming the purity, CLIC1 was dialysed into CLIC1 storage buffer, pH 7.0 (50 mM 
sodium phosphate, 0.02% NaN3, 1 mM DTT) using Snakeskin™ Pleated dialysis tubing 
MWCO 10 000 (Pierce). The purified protein used for all subsequent experiments was either 
snap-frozen with liquid nitrogen and stored at -80˚C or dialysed every week against a storage 
buffer containing 1 mM fresh DTT in order to maintain the protein under reducing conditions. 
Depending on the experiments, CLIC1 was also dialysed into acetate buffer (50 mM sodium 
acetate, 0.02% NaN3, 1 mM DTT, pH 5.5) for the studies performed at pH 5.5.  
 
2.2.3. Determination of protein concentration 
The concentration of purified CLIC1 was determined with ultraviolet (UV) absorbance 
spectroscopy before each experiment in order to ensure the integrity of the results. The 
Beer-Lambert law, A = εcl, was used. For a protein solution, A represents the absorbance at 
280 nm; ε is the molar extinction coefficient of the protein at 280 nm in M-1cm-1; c is the 
concentration of the protein solution in M and l is the path length of the cuvette in cm. The 
molar extinction coefficient of CLIC1 was determined based on the numbers of tryptophan, 
tyrosine and cysteine residues (Perkins, 1986):  
 
ε280 (M-1cm-1) = 5550 ΣTrp + 1340 ΣTyr + 150 ΣCys 
= 5550(1) + 1340(8) + 150(6)  
= 17170 M-1cm-1 
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The 280 nm absorbance readings of five serial dilutions (4X, 5X, 6X, 8X and 10X) of CLIC1 
stock were collected to construct a dilution curve. The absorbance at 340 nm that indicates 
the existence of aggregation was also collected for correction purposes. The absorbance at 
280 nm was corrected using the following equation (Reed et al., 2003): 
 
A280 (corrected) = A280 (protein) – A280 (buffer) – (A340 (protein) – A340 (buffer))(A280 (buffer) /A340 (buffer)) 
 
By fitting a linear regression analysis to the standard curve, the molar concentration of 
CLIC1 can then be calculated. Furthermore, an absorbance spectrum of purified CLIC1 was 
also collected over a wavelength range of 190 to 360 nm. DNA has a maximum absorbance 
at 260 nm while proteins absorb UV light mainly at 280 nm. The A280/A260 ratio of CLIC1 
was therefore used to assess DNA contamination. A ratio close to 1.8 generally indicates a 
pure protein with low DNA contamination. All absorbance measurements were performed on 
a Jasco V-550 UV/VIS spectrophotometer at 20˚C. 
 
2.2.4. Structural characterisation of CLIC1 
Far-UV circular dichroism spectroscopy 
Circular dichroism (CD) spectroscopy is a technique which is often used to characterise the 
structures of various biological molecules such as nucleic acids and proteins. The principle of 
this technique relies on the fact that optically active chromophores absorb right and left 
circularly polarised radiation components differently. When an equal amount of right and left 
polarised components of radiation pass through a sample at a given wavelength, an 
asymmetric chromophore does not absorb the two components equally. The differential 
absorption of two polarised components from the chromophore then gives the dichroism at 
the specific wavelength which is often expressed as either the ellipticity in degrees or the 
(2) 
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difference in absorbance of two components (reviewed by Kelly and Price, 1997). In proteins, 
the optically active chromophores are the peptide backbone, aromatic residues and disulfide 
groups (Woody, 1995). Far-UV CD is performed over a wavelength range of 190 ~ 250 nm 
to assess the content of global secondary structure of a protein. In this region, the main 
absorbing group is peptide bonds linking amino acid residues (Woody, 1995). It has been 
known that different regular secondary structures give different specific far-UV CD spectra 
(Woody, 1995). Therefore, far-UV CD is able to indicate characteristics of the secondary 
structural content of proteins. A predominantly α-helical protein has a specific spectrum with 
a strongly positive ellipticity near 190 nm and two dominant minima near 208 nm and    
222 nm (Woody, 1995). 
 
In this study, to characterise the secondary structures of CLIC1 in the native, intermediate and 
unfolded states, far-UV CD was performed. For far-UV CD spectra, each protein sample was 
made up with 10 µM CLIC1, CLIC1 storage buffer, pH 7.0 (50 mM sodium phosphate, 
0.02% NaN3, 1 mM DTT) or pH 5.5 (50 mM sodium acetate, 0.02% NaN3, 1 mM DTT) and 
different concentrations of urea (0 M and 7 M, which populate the native and unfolded state 
of CLIC1, respectively). Since the intermediate state of CLIC1 has exposed hydrophobic 
surface, it is prone to form aggregates while the protein concentration is high. Therefore, in 
order to prevent the formation of aggregates, the samples of intermediate state were made up 
with 2 µM CLIC1, in CLIC1 storage buffer (pH 7.0 or pH 5.5) and in the presence of 3.4 M 
urea (which populates the intermediate state of CLIC1 mostly). The spectra were obtained on 
a Jasco J-810 spectropolarimeter at 20˚C. The scan speed was 200 nm/min over a wavelength 
range of 190 ~ 250 nm, with a cuvette of path length 2 mm. The spectra were the result of 10 
accumulations.  
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For all the far-UV CD measurements, the unit, ellipticity, obtained from CD was converted 
into the mean residue ellipticity [Φ] (deg.cm2.dmol-1.residue-1) using the following equation: 
 
[Φ] = 100θ/cnl 
where θ is the ellipticity (mdeg); c represents the protein concentration in mM; n is the 
number of residues in the protein and l is the path length (cm) of the cuvette. All the CD 
spectra were smoothed using the negative exponential methodology (SigmaPlot® v11.0). 
 
Fluorescence spectroscopy 
Fluorescence spectroscopy is a type of electromagnetic spectroscopy that analyses the 
fluorescence of a sample (Lakowicz, 2006). When a fluorophore absorbs light of a specific 
wavelength, the electrons in the molecule which are in their ground state can be excited to a 
higher energy state. These electrons then fall back from the excited state to the ground state 
by losing electronic energy in the way of emitted light (that is, fluorescence). A common 
phenomenon known as Stoke’s shift is the explanation for the bathochromic (red) shift in the 
emission spectra compared to the excitation wavelength. In proteins, the amino acid residues 
which contribute to the fluorescence are mainly tyrosine and tryptophan. Tryptophan is the 
one which absorbs light at the longest wavelength and its extinction coefficient is the largest. 
Therefore, the energy from tyrosine is often transferred to tryptophan and thus the 
fluorescence of most proteins is dominated by tryptophan. In addition, tryptophan residues 
can be selectively excited at 295 nm in order to avoid the effect from tyrosine residues and 
make the fluorescence specific to that of the tryptophan residues rather than of Tyr-to-Trp 
energy transfer.  
 
The indole group of tryptophan is very sensitive to changes in environment polarity 
(Lakowicz, 2006). The wavelength at which tryptophan residues emit light depends on the 
(3) 
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polarity of the environment to which they are exposed. Since the polar solvent molecules 
lower the energy of the excited state, when a more polar environment surrounds the 
tryptophan residues, the spectrum will display a red shifted maximum emission wavelength 
toward a longer wavelength (Lakowicz, 2006). In contrast, if the environment is more 
nonpolar, the maximum emission wavelength shows a blue shift toward to a shorter 
wavelength. Therefore, the location of tryptophan residues in the protein can be inferred and 
fluorescence spectroscopy can be used as a probe to monitor the change in tertiary structure 
of a protein, specifically in the microenvironment surrounding the tryptophan residues. 
 
For the fluorescence spectroscopy measurements, each protein sample was made up with   
10 µM CLIC1, in CLIC1 storage buffer, pH 7.0 (50 mM sodium phosphate, 0.02% NaN3,   
1 mM DTT) or pH 5.5 (50 mM sodium acetate, 0.02% NaN3, 1 mM DTT) and different 
concentrations of urea (0 M and 7.M, which populate the native and unfolded state of CLIC1, 
respectively). As mentioned in the far-UV CD section, in order to avoid the formation of 
aggregation, the representative samples of the intermediate state of CLIC1 were made up 
with 2 µM CLIC1, in CLIC1 storage buffer, pH 7.0 or pH 5.5 and in the presence of 3.4 M 
urea (where the intermediate populates mostly). The spectra were measured on a 
Perkin-Elmer Luminescence Spectrometer LS50B at 20˚C. The scan speed was 100 nm/min 
over a wavelength range of 280 ~ 450 nm using a cuvette of path length 10 mm. The 
excitation wavelengths were 280 nm and 295 nm to excite both tyrosine and tryptophan 
residues and to selectively excite only the tryptophan residue, respectively. The spectra were 
the result of 10 accumulations. All the fluorescence spectra were smoothed using the negative 
exponential methodology (SigmaPlot® v11.0). 
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2.2.5. Urea-induced equilibrium unfolding 
Equilibrium unfolding is a process of unfolding a protein by gradually changing its 
environment with a chemical denaturant, temperature change or pH change. The functions of 
denaturation curves include comparing conformational stability among proteins, observing 
equilibrium unfolding intermediates and further indicating unfolding and folding pathway of 
proteins (see Section 1.2.1.). Since the existence of unfolding intermediates often indicates 
that the protein has more than one domain and that it unfolds following a more complex 
pathway, denaturation curves are also able to give information about the structure (number of 
domains) of a protein. For equilibrium unfolding studies, two important thermodynamic 
parameters can be obtained: ∆G(H2O) and m-value. The ∆G(H2O) of an unfolding reaction is 
defined as the change in free energy between the native and the unfolded state in the absence 
of denaturant. It serves as an indication of the conformational stability of proteins. The 
m-value is the slope of the transition region of unfolding curves. It has been shown that 
m-values are related to the surface area of proteins exposed to solvent during unfolding 
(Myers et al., 1995). Equilibrium unfolding of CLIC1 has been previously studied (Fanucchi 
et al., 2008). However, in order to determine the precise conditions which are required for the 
subsequent kinetics experiments, the equilibrium unfolding of CLIC1 was repeated. 
 
Recovery studies 
Since the equilibrium constant of the unfolding reaction is required for calculating the free 
energy change between the native and the unfolded state, it is essential to make sure that the 
unfolding reaction is at equilibrium and hence reversible (Pace, 1986). The recovery and 
reversibility of wild type CLIC1 have both been previously demonstrated (McIntyre PhD 
thesis 2008; Fanucchi et al., 2008). Therefore, in this study, recovery studies of native CLIC1 
were just performed to demonstrate the CLIC1 unfolding process is reversible. 
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Recovery studies were conducted by unfolding 20 µM CLIC1 in 7 M urea at pH 7.0 (50 mM 
sodium phosphate, 0.02% NaN3, 1 mM DTT) or pH 5.5 (50 mM sodium acetate, 0.02% NaN3, 
1 mM DTT) at 20˚C for 2 hours or 1 hour to reach equilibrium, respectively. Unfolded 
CLIC1 was then diluted 10X to a final concentration of 2 µM protein in 0.7 M urea and 
allowed to refold for 1 hour. Far-UV CD and fluorescence spectroscopy were used as probes 
to detect changes in secondary and tertiary structure. The spectra of 2 µM native and 
unfolded CLIC1 (in 0.7 M and 7 M urea, respectively) were used as controls. The CD and 
fluorescence spectra were collected over wavelength ranges of 190 ~ 250 nm and        
280 ~ 450 nm, respectively. The excitation wavelength for fluorescence measurements was 
280 nm. 
 
Sample preparation 
Equilibrium unfolding of CLIC1 was performed using urea as the denaturant. Samples and 
urea stock (10 M) were made up with CLIC1 storage buffer, pH 7.0 (50 mM sodium 
phosphate, 0.02% NaN3, 1 mM DTT) or pH 5.5 (50 mM sodium acetate, 0.02% NaN3, 1 mM 
DTT). Samples of 2 µM CLIC1 were prepared in urea concentrations ranging from 0 to 8 M 
at both pH 7.0 and pH 5.5. After sample preparation, unfolding at pH 5.5 and pH 7.0 were 
allowed to unfold at 20˚C for one and two hours, respectively, in order to reach equilibrium. 
Far-UV CD and fluorescence spectroscopy were used as probes to monitor structural changes 
of CLIC1 in the equilibrium unfolding studies.  
 
Far-UV CD measurements 
As mentioned previously, since CLIC1 is a predominantly α-helical protein, the CD spectra 
for CLIC1 show a specific signature of two minima at 208 nm and 222 nm, respectively. 
Furthermore, the signal at 222 nm of a native helical-protein is relatively larger when 
compared to the low signal at 222 nm from its unfolded structure. Therefore, the ellipticity at 
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222 nm was chosen as a probe to detect any change in secondary structure of CLIC1 in the 
equilibrium unfolding studies as the denaturant concentration increases. The ellipticity at  
222 nm was recorded over a urea concentration range of 0 to 8 M. The CD measurement was 
conducted over 60 seconds with 0.5 second interval for each sample and then averaged. For 
each urea concentration, the final result was obtained from the average of three experiments. 
 
Fluorescence measurements 
When excited at either 280 nm or 295 nm, CLIC1 has a maximum fluorescence emission 
wavelength at 345 nm. However, excitation at 295 nm resulted in a rather small quantum 
yield compared to excitation at 280 nm. Therefore, 280 nm was chosen to be the excitation 
wavelength for the equilibrium unfolding studies of CLIC1. For fluorescence measurements 
of equilibrium unfolding, the emission spectrum was recorded over a wavelength range of 
280 ~ 450 nm for each sample over a urea concentration range of 0 to 8 M. The excitation 
wavelength was 280 nm. The scan speed was 350 nm/min. The path length of cuvette was  
10 mm. Each spectrum was the result of 3 accumulations. 
 
Since tryptophan fluorescence spectroscopy is sensitive to environmental polarity, the 
maximal emission wavelength is usually used as a probe to monitor any change in the 
microenvironment of tryptophan residues (Lakowicz, 2006). However, tryptophan 
fluorescence spectroscopy is also sensitive to changes in protein concentration. Change in 
protein sample concentration can lead to change of the emission intensity. Therefore, 
intensity-averaged emission wavelength (IAEW) is a better way to measure any change in the 
spectral shift or in the shape of spectra than the emission maximum wavelength because it 
takes both intensity and wavelength of an entire spectrum into account (Royer et al., 1993). 
In addition, IAEW is also an integral measurement and thus it is able to avoid instrumental 
noise. IAEWs <λ> of fluorescence-monitored equilibrium unfolding data were calculated 
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using the following equation: 
<λ> = ∑
N
i
(Iiλi)  ∑
N
i
(Ii) 
where Ii is the intensity at wavelength λi and i represents any point along entire spectrum.  
 
ANS binding 
ANS, a hydrophobic fluorescent dye, is often used as a probe to examine the nonpolar 
character of macromolecules such as membranes and proteins. ANS is an amphipathic 
molecule with a hydrophobic naphthalene part and a negatively charged sulfonate group. 
Binding of ANS to proteins is mainly initiated through the electrostatic interaction between 
the cationic groups on proteins and the ANS sulfonate group (Matulis and Lovrien, 1998). 
Therefore, the cationic charge of a protein and the pH of the protein solution are both able to 
influence the binding of ANS. However, the most important property of this dye is that the 
hydrophobic naphthalene moiety of ANS is able to bind to the hydrophobic clusters on 
macromolecules. When ANS is excited alone in water, the emission maximum is above   
500 nm with a very small quantum yield (Lakowicz, 2006). Once ANS binds to the nonpolar 
clusters on a protein, the maximum emission wavelength of the fluorescence spectrum will 
display a blue shift (shift to a lower wavelength) and the quantum yield increases largely 
(Lakowicz, 2006). Since unfolding intermediates usually have exposed hydrophobic surface, 
ANS is often used to detect the existence of intermediates in protein unfolding reactions in 
both equilibrium unfolding and unfolding kinetics studies (Stryer, 1965; Kuwajima et al., 
1991; Semisotnov et al., 1991). 
 
ANS binding was conducted along with equilibrium unfolding experiments of CLIC1 at   
pH 7.0 and pH 5.5 to detect the formation of the intermediate. ANS stock was prepared to   
2 mM. After the protein was allowed to unfold to reach equilibrium at different urea 
(4) 
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concentrations, ANS was added from the stock to each sample to a final concentration of  
200 µM and allowed to bind for one hour. The spectrum (390 ~ 600 nm) for each sample was 
recorded on the fluorimeter with an excitation wavelength of 390 nm. The scan speed was 
500 nm/min. A cuvette of path length 10 mm was used. Each final spectrum was the result of 
3 accumulations. After ANS binds to the intermediate state of CLIC1, the ANS spectrum 
displays a maximum emission wavelength of ~460 nm. Therefore, the ANS binding as a 
function of urea was plotted using the fluorescence intensity at 460 nm. All the spectra of 
ANS binding were corrected with blank controls (free ANS + urea at different 
concentrations).  
 
Data analysis 
The data chosen to construct unfolding curves were CD ellipticity at 222 nm and fluorescence 
intensity at 310 nm and 345 nm. The spectra of native CLIC1 show a maximum emission 
wavelength at ~345 nm. The maximum emission wavelength of unfolded CLIC1 shifts to 
~356 nm. Like CD ellipticity at 222 nm, the fluorescence intensity at 345 nm displays a 
relatively large difference between the spectra of native and unfolded CLIC1. It can, therefore, 
serve as a good probe to monitor changes in tertiary structure of CLIC1. Previous equilibrium 
unfolding studies at pH 5.5 have shown that, when plotted using emission intensity at 310 nm, 
the unfolding curve of CLIC1 does not display a single sigmoidal transition (Fanucchi et al., 
2008). Therefore, fluorescence intensity at 310 nm was selected as a probe to demonstrate the 
appearance of the intermediate. In addition, the IAEW of CLIC1 was also plotted against urea 
concentration of 0 ~ 8 M to create unfolding curves as an indication of the intermediate. 
 
The unfolding curves (F310, F345, and E222) obtained from equilibrium unfolding studies at  
pH 7.0 and at pH 5.5 were globally fit to a two-state model or a three-state model, 
respectively. Global analyses of data involve the simultaneous analysis of multiple data sets 
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from different experiments with reference to internally unified sets of fitting parameters 
(Beechem, 1992). The advantage of global analysis is that using consistent parameters to 
analyse all sets of data gives more precise results than the separate fits. All the data fitting 
were performed using a nonlinear least-squares programme, Savuka 6.2.26 (Zitzewitz et al., 
1995; Bilsel et al., 1999). 
 
Two-state monomer unfolding mechanism:  
A two-state equilibrium unfolding mechanism for a monomeric protein is presented as N ↔ U, 
where N and U represent the native and the unfolded states, respectively. This mechanism 
assumes that the protein can only be in the native state or in the unfolded state along the 
unfolding transition. Therefore, if we sum up the fraction of the native protein (fN) and the 
fraction of the unfolded protein (fU), the value is 1. 
fN + fU = 1 
The observed values (y) using CD or fluorescence as a probe at any point along the unfolding 
transition will be: 
y = yNfN + yUfU 
where y is the recorded value obtained from CD or fluorescence; yN and yU are the values of y 
of the native and unfolded protein, respectively. Then, combining equation 5 and 6 leads to: 
fU = (yN – y) ( yN – yU ) 
fN = (yU – y) (yU – yN) 
An equilibrium constant between the native protein and the unfolded protein, Keq, can be 
calculated using the following equation:  
Keq = fU fN 
       = (yN – y) ( y – yU ) 
 
 
(5) 
(6) 
(7) 
(8) 
(9) 
 51 
The free energy change, ∆G, is a measure of stability of a protein in the unfolding reaction. 
∆G will be: 
∆G = -RT ln Keq 
∆G = -RT ln [ (yN – y) ( y – yU ) ] 
where R represents the universal gas constant (1.987 cal. mol-1. K-1); T is the temperature in 
kelvin. 
 
Two important parameters, ∆G(H2O) and the m-value, can be obtained from equilibrium 
unfolding curves using the linear extrapolation method (Greene and Pace, 1974). This method 
is based on the assumption that ∆G has a linear dependence on denaturant concentration in 
the transition region and can be tracked back to zero denaturant concentration to obtain the 
∆G values in the absence of denaturant (∆G(H2O)) using the following equation: 
∆G = ∆G(H2O) – m[denaturant] 
 
In a two-state unfolding mechanism, the Cm value represents the midpoint of the unfolding 
curves and is defined as the denaturant concentration at which the native and the unfolded 
species are equally populated at equilibrium. The Cm value was obtained using the equation: 
Cm = ∆G(H2O) m 
 
Three-state monomer unfolding mechanism:  
A three-state equilibrium unfolding mechanism for a monomeric protein is presented as 
N ↔ I ↔ U, where I represents the intermediate detected at equilibrium. This mechanism 
states that the protein can be in the native, intermediate or the unfolded state. Therefore, the 
sum of fraction of the native, intermediate and unfolded protein can be written as:  
fN + fI + fU = 1 
where fN, fI and fU represents the fraction of the native, intermediate and unfolded protein, 
(10) 
(11) 
(13) 
(12) 
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respectively. In this model, there are two equilibrium constants: K1 for the N ↔ I transition 
and K2 for the I ↔ U transition. The equilibrium constants K1 and K2 can be written as: 
K1 = fI fN 
K2 = fU fI 
Therefore, the equilibrium constant for the whole reaction (N ↔ U transition) is: 
KU = K1 K2 
The observed signal, y, can be written as: 
y = yNfN + yIfI + yUfU 
In terms of K1 and K2, equation 13 can be described as: 
fU + (fU K1 K2) + (fU K1 ) = 1 
Therefore, we can get: 
fU = K1 K2 K1 K2 + 1 + K1 
fI = K1  K1 K2 + 1 + K1 
fN = 1 [ ( K1 K2 + 1 + K1 ) (K1 K2) ] 
 
The ∆G(H2O)I and ∆G(H2O)II can be obtained from equation 22 and 23: 
∆G(H2O)I = -RT ln K1 
∆G(H2O)II = -RT ln K2  
Also, 
∆GI = ∆G(H2O)I - mI [denaturant] 
∆GII = ∆G(H2O)II - mII [denaturant] 
where subscript I and II represent the N ↔ I and I ↔ U transitions, respectively.  
 
Therefore,  
K1 = e (mI [denaturant] -∆G(H2O)I) RT 
K2 = e (mII [denaturant] -∆G(H2O)II) RT 
(14) 
(15) 
(16) 
(22) 
(23) 
(17) 
(18) 
(19) 
(20) 
(21) 
(24) 
(25) 
(26) 
(27) 
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Combining equations 19 ~ 27 with equation 17, the final fit is obtained as: 
y = [ yN+ yI K1 + yU K1 K2 ] [ 1 + K1 + K1 K2 ] 
where K1 is e (mI [denaturant] -∆G(H2O)I) RT and K2 is e (mII [denaturant] -∆G(H2O)II) RT. 
 
From the three-state global fit, ∆G(H2O)I and ∆G(H2O)II were obtained. The fractional 
population of the native, the intermediate and the unfolded protein was calculated from K1 
and K2 using equation 19 to 21. 
 
2.2.6. Unfolding kinetics 
Equilibrium unfolding studies provide information about conformational stability of proteins 
while unfolding kinetics studies are used to detect the presence of transient intermediates that 
emerge during the unfolding process and enable the construction of the specific unfolding 
pathway. In this study, the kinetics of CLIC1 unfolding was separated into three sections: 
unfolding from the native state (N) to the unfolded state (U), from N to the intermediate state 
(I), and from I to U. All the unfolding experiments were conducted with a final concentration 
of 2 µM CLIC1 at 20˚C using a manual mixing method. The CD ellipticity at 222 nm (E222) 
and fluorescence intensity at 345 nm (F345) with an excitation wavelength of 280 nm were 
used as probes to monitor any change in structure of the protein over time. To prevent the 
separation of urea from the buffer, a stirring apparatus was used for all 
fluorescence-monitored unfolding kinetic experiments.  
 
For unfolding kinetics of the N →U transition, native CLIC1 was added to a solution of a 
final concentration of 5.5 M to 8 M urea (which represents the posttransition region in the 
equilibrium unfolding studies) at pH 7.0 and pH 5.5 to produce unfolded protein. The data 
recording time ranges using fluorescence and CD as probes for the N →U transitions at   
(28) 
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pH 7.0 and pH 5.5 were at most 2 hours and 10 minutes, respectively. Since the intermediate 
state is only detectable at pH 5.5, the unfolding experiments of the N → I and the I →U 
transitions were only performed at pH 5.5. For the unfolding experiments of the N → I 
transition, native CLIC1 was added to a solution of a final concentration of 3 to 4 M urea 
(which corresponds to the condition where the intermediate appears in the equilibrium 
unfolding studies). The unfolding traces of the N → I transition were recorded using both 
probes over at most 1 hour. For the I →U transition, CLIC1 was incubated in the presence of 
3.4 M urea (the condition where the intermediate is most populated) for one hour to obtain 
the equilibrium intermediate. The intermediate was then unfolded in the presence of 5.5 to  
7 M urea and the unfolding traces were recorded over at most 20 minutes.  
 
The native baselines (the N →U transition and the N → I transition) were obtained from the 
signal of native protein at both pH values. The intermediate baselines for the N → I and the 
I →U transition were constructed by measuring the signal of native protein incubated in the 
presence of 3 ~ 4 M or 3.4 M urea for at least one hour, respectively. The unfolded baselines 
(the N → U and the I → U transition) were acquired from the signal of native protein 
incubated in the presence of 5 to 7 M urea (depending on the experiments) for at most 2 hours. 
All the measurements were repeated three times. The data analysis was done on all of the 
three recorded kinetic traces from each experiment using SigmaPlot® v11.0 and the results of 
analysis were then averaged. 
 
Data analysis 
In this study, all the kinetics data were fit to the exponential decay model. Depending on the 
data, the kinetics trace was fitted to either a single or double exponential model. However, 
there was an exception: the N → I transition. For this transition, all the 
fluorescence-monitored traces were fitted to two separate single exponential models using the 
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minimum of each trace as a boundary. The single and double exponential models can 
described using the general equation shown in the following: 
A(t) = y0 + ∑ Aie
-Kit
 
A(t) represents the observed ellipticity from circular dichroism or the observed fluorescence 
intensity, t is time, y0 is the amplitude from the beginning to the end of each kinetic trace at 
given time, Ki and Ai are the apparent rate constant and the amplitude of the phase i, 
respectively. The residuals for each plot were computed to facilitate better choice of the two 
models and presented to indicate the quality of each fitting. The obtained apparent unfolding 
rate constants for each trace were then plotted against different final urea concentrations to 
construct chevron plots. To obtain the unfolding rate constant in the absence of denaturant, 
every chevron plot was fit to linear regression using the following equation: 
log (ku) = log (ku(H2O)) + mu [denaturant] 
where ku is the apparent rate constant for unfolding at different urea concentrations, ku(H2O) 
is the value of apparent unfolding rate in the absence of denaturant, and mu represents the 
amount of exposed surface area to the solvent at different denaturant concentrations during 
unfolding.  
 
 
 
 
 
 
 
 
 
(29) 
(30) 
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3. Results 
3.1. CLIC1 expression and purification 
SDS-PAGE (Figure 6) was utilised to demonstrate the process of the purification and to 
confirm the purity of purified CLIC1. IPTG (final concentration 1 mM) was confirmed to 
induce the overexpression of GST-CLIC1 fusion protein (Figure 6A, lanes 2 and 3). The 
GST-CLIC1 fusion protein demonstrates a molecular weight of approximately 58 kDa on the 
SDS-PAGE gel. After harvesting, the fusion protein appeared to be soluble and was mainly 
present in the supernatant compared to the small fraction of insoluble protein, which 
remained in the pellet (Figure 6A, lanes 4 and 5). The fusion protein was separated from all 
other cellular proteins by using the affinity between the GST fusion protein and a 
GSH-coated resin, GSH-Sepharose. The supernatant of the lysed cells was loaded on the 
GSH-Sepharose column and the flow-through was collected once the fusion protein bound to 
the column. Comparing the much smaller band representing the fusion protein in the 
flow-through with the larger band of the fusion protein in the supernatant indicates that most 
of the fusion protein was captured and retained on the GSH-Sepharose column (Figure 6A, 
lanes 4 and 6).  
 
Thrombin was used to separate fused GST and CLIC1. After thrombin cleavage on the 
GSH-Sepharose column for 16 hours, CLIC1 and thrombin were recovered from the 
GSH-Sepharose column (Figure 6B, lane 2). The GST remained bound to the column and 
was then eluted with a high concentration of GSH. The eluted GST is displayed on the gel 
along with a band at 58 kDa representing uncleaved fusion protein (Figure 6B, lane 3). Since 
the band of uncleaved fusion protein is tiny when compared to the thick band of the cleaved 
GST, the cleavage was relatively efficient. 
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Figure 6: SDS-PAGE gels illustrating a representative purification process of CLIC1 
(A) Lane 1 contains molecular weight markers; lanes 2 and 3 contain whole E. coli cell 
extract before and after induction with 1 mM IPTG, respectively; lanes 4 and 5 contain 
supernatant and pellet of the lysed cells, respectively. Lane 6 shows the flow-through from 
the GSH-sepharose column indicating that most of the fusion protein bound. The GST-CLIC1 
fusion protein is displayed on the gel with a molecular mass of approximately 58 kDa. (B) 
Lane 1 contains a molecular weight marker. Lane 2 shows CLIC1 and thrombin mixture 
recovered from the GSH-Sepharose column. Lane 3 displays the cleaved GST with a small 
amount of uncleaved fusion protein from the GSH-sepharose column. Lane 4 contains the 
separated thrombin. Purified CLIC1 with an apparent molecular mass of approximately    
32 kDa is shown in lane 5. 
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CLIC1 has a pI value of 4.85, and thus it is negatively charged at pH 6.5 and binds to the 
positively charged DEAE-Sepharose resin. Thrombin, in constrast, with a pI value of 7~7.6 
(Fenton et al., 1977) is positively charged and does not bind to the DEAE-Sepharose resin at 
pH 6.5. Therefore, the CLIC1 recovered from the GSH-Sepharose column was able to be 
separated from thrombin by DEAE anion exchange chromatography at pH 6.5. Human 
thrombin demonstrates a molecular weight of 36.6 kDa on SDS-PAGE gels (Fenton et al., 
1977). In this study, the eluted thrombin migrates a distance which corresponds to a 
molecular size of approximately 34 kDa (Figure 6B, lane 4) on the SDS-PAGE gel, which is 
slightly smaller when compared to the result shown by Fenton et al., 1977. The DEAE-bound 
CLIC1 was then eluted with an increased salt concentration of 300 mM NaCl at pH 6.5. 
Purified CLIC1 demonstrates a molecular weight of approximately 32 kDa (Figure 6B, lane 5 
and Figure 7). The theoretical molecular weight of CLIC1 is 26.9 kDa. It has been 
demonstrated that CLICs, on SDS-PAGE gels, display a higher molecular weight than their 
theoretical molecular weights (Tulk and Edwards, 1998; Berryman and Bretsher, 2000; Tulk 
et al., 2000; Board et al., 2004). A possible reason for this unusual migration is that the acidic 
nature of CLIC1 has an influence on SDS binding (Lehtovaara, 1978). The negative charge of 
CLIC1 might reduce the SDS:protein ratio and further lower the mobility of the protein. To 
conclude, the lone band of the CLIC1 sample indicates that CLIC1 was purified successfully. 
 
For protein concentration determination of CLIC1, the Beer-Lambert law was used. The yield 
of CLIC1 from 4 litres of cell culture was calculated to be approximately 80 mg. The 
A280:A260 ratio was close to 1.8, indicating that there was no significant DNA contamination 
(Figure 8). 
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Figure 7: Calibration curve obtained from the SDS-PAGE gel 
The curve was constructed from the log values of the molecular weight (in kDa) of molecular 
weight marker against their migrated distances on the gel. The molecular weight of CLIC1 
was calculated as 32 kDa. 
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Figure 8: Absorbance spectrum of purified CLIC1 
The absorbance of CLIC1 at 280 nm is 1.14, this corresponds to a protein concentration of  
66 µM. There is no significant DNA contamination detectable in the purified protein since the 
A280:A260 ratio is close to 1.8. The negligible absorbance at 340 nm indicates that the level of 
aggregation is negligible. 
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3.2. Structural characterisation of CLIC1 
 
Secondary structure 
Far-UV CD (190-250 nm) was performed to study the secondary structural content of the 
native and unfolded states of CLIC1 at pH 7.0 and pH 5.5. Two minima at 208 and 222 nm 
are shown in the spectra of native CLIC1 at both pH values (Figure 9), which is typical for 
α-helical proteins (Woody, 1995). 
 
The CD spectra of native CLIC1 at pH 5.5 shows about 18% reduction in the CD signal 
compared to at pH 7.0 (Figure 9). This indicates a lower secondary structural content under 
this condition (at pH 5.5). However, the two clear minima demonstrate that the entire 
secondary structure is still mainly α-helical and not significantly different from the one at  
pH 7.0. The result suggests that the pH level only has a small effect on the secondary 
structure of the native state of CLIC1. 
 
The spectra of unfolded CLIC1 at pH 7.0 and pH 5.5 both display a spectral signature of 
random coil structures (Woody, 1995), suggesting that CLIC1 is unfolded in the presence of  
8 M urea at either pH 7.0 or pH 5.5 and most of the predominantly α-helical secondary 
structure is disrupted (Figure 9). 
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Figure 9: Comparison of the circular dichroism spectra of CLIC1 at pH 7.0 and pH 5.5 
Far-UV CD spectra of 10 µM CLIC1 at pH 7.0 (blue) and pH 5.5 (pink) recorded at 20˚C. 
The buffers used: pH 7.0 (50 mM sodium phosphate, 0.02% NaN3, 1 mM DTT) and pH 5.5 
(50 mM sodium acetate, 0.02% NaN3, 1 mM DTT). Two minima, one at 208 nm and one at 
222 nm in the spectra of native CLIC1 (closed circles) are indicated by arrows. In the 
presence of 8 M urea, the spectra of unfolded CLIC1 at both pH 7.0 and pH 5.5 display a 
spectral pattern typical for random coil (solid lines). The spectra were smoothed using the 
negative exponential methodology (SigmaPlot® v11.0). 
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Tertiary structure 
The tertiary structure of CLIC1 was monitored using fluorescence spectroscopy. This 
technique demonstrates specifically the environment surrounding tryptophan residues 
(Lakowicz, 2006). Fluorescence resonance energy transfer (FRET) is a mechanism of energy 
transfer between a donor chromophore in its excited state and an acceptor chromophore. In a 
protein, the chromophores are mainly tyrosine and tryptophan residues. When a protein is 
excited at 280 nm, both tyrosine and tryptophan residues are excited resulting in FRET to the 
final acceptor, the tryptophan residues (Lakowicz, 2006). CLIC1 has only one tryptophan, 
Trp35, which is located in the putative transmembrane region in the N-domain (see Figure 4) 
(Harrop et al., 2001). In the case of CLIC1 which has one tryptophan and eight tyrosine 
residues, excitation at 280 nm results in a higher quantum yield than excitation at 295 nm 
which only excites the tryptophan residue (Figure 10).  
 
The fluorescence spectra of native CLIC1 at both pH 7.0 and pH 5.5 show a maximum 
emission wavelength of 345 nm (Figure 10). The intensities of the spectra are also similar at 
both pH values. The maximum emission wavelength shifts when tryptophan residues are 
exposed to environments of different polarity (Lakowicz, 2006). The fact that the maximum 
emission wavelengths of the spectra at pH 7.0 and pH 5.5 are identical indicates that the 
location of the lone tryptophan residue of native CLIC1 at both pH values is similar. This 
suggests that the tertiary structure, specifically around Trp35, is not influenced by changes in 
pH. In the presence of 8 M urea, the maximum emission wavelength of unfolded CLIC1 
shows a red shift to 356 nm (Figure 10), which indicates the exposure of the tryptophan 
residue to the polar solvent. The unfolding of CLIC1 also increases the distance between the 
lone tryptophan and the tyrosine residues, resulting in the FRET from the tyrosine to the 
tryptophan being disrupted. Therefore, the quantum yields of the spectra of unfolded CLIC1 
are reduced and the emission from the tyrosine residues can be seen as a shoulder at 310 nm. 
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Figure 10: Comparison of the fluorescence spectra of CLIC1 at pH 7.0 and pH 5.5 
Fluorescence emission spectra of 10 µM CLIC1 at pH 7.0 (blue) and pH 5.5 (pink) when 
excited at 280 nm (circles) or 295 nm (squares) recorded at 20˚C. Native CLIC1 (closed 
symbols) has a maximum emission wavelength of 345 nm (indicated by the red arrow) when 
excited at either 280 nm or 295 nm. Unfolded CLIC1 (open symbols) shows a red-shifted 
emission wavelength of 356 nm (indicated by the grey arrow) when excited at 280 nm and 
has a shoulder at 310 nm (indicated by the green arrow). When unfolded CLIC1 is excited at 
295 nm, the spectra peak at 360 nm. The buffers used: pH 7.0 (50 mM sodium phosphate, 
0.02% NaN3, 1 mM DTT) and pH 5.5 (50 mM sodium acetate, 0.02% NaN3, 1 mM DTT). All 
the spectra were smoothed using the negative exponential methodology (SigmaPlot® v11.0). 
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3.3. Urea-induced equilibrium unfolding 
3.3.1. Recovery studies 
It is very important for equilibrium unfolding data analysis that the unfolding reaction is at 
equilibrium and is reversible (Pace, 1986). Therefore, the reversibility of unfolding of a 
protein needs to be established in order to enable the analysis of its thermodynamic 
parameters obtained from equilibrium unfolding studies (Pace, 1986). Recovery and 
reversibility studies of CLIC1 have been previously demonstrated by Fanucchi et al., 2008. 
The recovery of the secondary and tertiary structure of CLIC1 was conducted by denaturing 
native CLIC1 in the presence of 7 M urea then diluting it ten times so as to refold it. Both 
circular dichroism and tryptophan fluorescence were used as probes to detect any change in 
secondary and tertiary structure. In this study, the recovery monitored by CD at pH 7.0 and 
pH 5.5 is 93% and 91%, respectively (Figure 11A). The fluorescence-monitored recovery at 
pH 7.0 and pH 5.5 is 96% and 97%, respectively (Figure 11B). The high recovery of the 
native structure at pH 7.0 and pH 5.5 indicates that the unfolding of CLIC1 is reversible after 
denaturation in the presence of 7 M urea at both pH values. Therefore, the equilibrium 
unfolding curves of CLIC1 can be analysed in terms of the thermodynamic parameters. 
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Figure 11: Recovery of secondary and tertiary structure of CLIC1 
Recovery of secondary (A) and tertiary (B) structure of CLIC1 at pH 7.0 (blue) and pH 5.5 
(pink). Twenty microlitres of CLIC1 was unfolded in the presence of 7 M urea and diluted 
10X to refold to a concentration of 2 µM protein in 0.7 M urea. The spectra of native and 
unfolded CLIC1 (7 M urea) are shown as references and are indicated with closed circles and 
solid lines, respectively. The spectra of refolded CLIC1 are given by dashed lines. All the 
spectra were smoothed using the negative exponential methodology (SigmaPlot® v11.0). 
A 
B 
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3.3.2. Effect of pH on the conformational stability of CLIC1 
Equilibrium unfolding studies were performed using CD and fluorescence spectroscopy as 
probes to monitor changes in secondary and tertiary structure, respectively. The influence of 
pH on the equilibrium unfolding of CLIC1 is shown in Figure 12. At pH 7.0, the CD- and 
fluorescence-monitored unfolding curves, especially in the transition region, coincide within 
error and show a monophasic transition (Figure 12A). This behaviour suggests a cooperative 
two-state unfolding process, N ↔ U, where N and U represent the native and the unfolded 
states, respectively. Therefore, a two-state model was used to globally fit the unfolding data at 
pH 7.0. The global fit of the CD- and fluorescence-monitored data at pH 7.0 gives a ∆G(H2O) 
of 7.9 ± 0.46 kcal/mol and a m-value of 1.8 ± 0.11 kcal/mol/M urea (Table 2). 
 
At pH 5.5, the F345 -monitored curve also shows a single sigmoidal transition. However, the 
F310 - and E222 -monitored curves display more than one transition (Figure 12B). This 
suggests that the unfolding of CLIC1 at pH 5.5 cannot be described using a two-state 
mechanism. Therefore, the unfolding data monitored at pH 5.5 were globally fit to a 
three-state model, N ↔I ↔ U, where I represents an intermediate. The ∆G(H2O) and m-value 
for forming the intermediate species (the N ↔I transition) are 6.7 ± 1 kcal/mol and 2.5 ± 0.45 
kcal/mol/M urea, respectively (Table 2). The ∆G(H2O) and m-value for unfolding the 
intermediate (the I ↔U transition) are 13.7 ± 2.1 kcal/mol and 3.5 ± 0.5 kcal/mol/M urea, 
respectively. The ∆G(H2O) of the N ↔I transition is smaller than the one of the I ↔U 
transition, suggesting that these conditions are conducive to the formation of the intermediate 
of CLIC1. 
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Figure 12: Equilibrium unfolding of CLIC1 at pH 7.0 and pH 5.5 
A 
B 
C 
D 
 69 
Equilibrium unfolding experiments conducted on 2 µM CLIC1 at 20˚C as a function of urea 
at pH 7.0 (A) and pH 5.5 (B). In (A) and (B), the ellipticity at 222 nm (blue) and the 
fluorescence emission intensity at 310 nm and 345 nm (red and green, respectively) were 
used as probes. The solid lines represent the global fit of a two-state (A) and a three-state (B) 
model to the data. The IAEW and ANS binding as a function of urea are shown in (C) and 
(D), respectively, where data monitored at pH 7.0 and pH 5.5 are indicated in blue and pink, 
respectively. The buffers used: pH 7.0 (50 mM sodium phosphate, 0.02% NaN3, 1 mM DTT) 
and pH 5.5 (50 mM sodium acetate, 0.02% NaN3, 1 mM DTT).  
 
 
 
Table 2: Comparison of the thermodynamic parameters obtained from the equilibrium 
unfolding studies at pH 7.0 and pH 5.5 
 
  pH 7.0 pH 5.5 
 
N ↔ U N ↔ I I ↔ U 
∆G(H2O) 
(kcal/mol) 7.9 ± 0.46  6.7 ± 1 13.7 ± 2.1 
m-value 
(kcal/mol/M urea) 1.8 ± 0.11 2.5 ± 0.45 3.5 ± 0.5 
Cm 
(M urea) 4.2 2.7 3.9 
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The existence of the intermediate is further confirmed by intensity-averaged emission 
wavelength (IAEW) changes along the equilibrium unfolding transition and ANS binding 
studies (Figure 12 panel C and D). At pH 7.0, the IAEW curve of the fluorescence-monitored 
unfolding shows a single transition. At pH 5.5, a minimum at 3.4 M urea of the IAEW curve 
indicates that the unfolding does not follow a two-state mechanism. This transition occurs at 
the same urea concentrations that the peak of the F310-monitored unfolding curve occurs. 
Furthermore, the decrease in IAEW at 2.5 ~ 4 M urea suggests that the location of the lone 
tryptophan moves to a more nonpolar environment than the native state under this condition.  
 
ANS is a fluorescent dye which binds to hydrophobic patches on proteins and is often used to 
detect unfolding intermediates (Stryer, 1965; Semisotnov et al., 1991). ANS does not bind to 
CLIC1 in the native and unfolded state or at any point along the unfolding transition at pH 
7.0 (Figure 12D). At pH 5.5, the binding of ANS increases from 2 to 5.5 M urea and peaks at 
3.4 M urea which corresponds to the condition where the decrease in IAEW and the peak in 
the F310- monitored curve occur (Figure 12 C and D). 
 
In addition, the population plot calculated from the global fitting shows that the intermediate 
is most highly populated in the presence of 3.4 M urea. Approximately 91% of species are in 
the intermediate state under this condition (Figure 13). The high intermediate population is 
significant for the feasibility of the subsequent kinetics studies (the N → I and I → U 
transitions). 
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Figure 13: Fractional populations plot of CLIC1 as a function of urea concentrations at 
pH 5.5 
The populations were obtained from the global fitting of the equilibrium unfolding to a 
three-state model. The native (N), unfolded (U) and intermediate (I) populations are indicated 
in solid, dashed and dotted lines, respectively. 
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3.3.3. Structure of the intermediate 
The equilibrium unfolding studies of CLIC1 at pH 5.5 indicate the appearance of an 
intermediate species that is stable at equilibrium under mild denaturing conditions (Figure 12). 
In order to obtain the intermediate species, CLIC1 was incubated in the presence of 3.4 M 
urea at pH 5.5, which corresponds to the highest population of the intermediate relative to the 
native and unfolded state. The secondary and tertiary structure of the intermediate state of 
CLIC1 were then further characterised using far-UV circular dichroism and intrinsic 
tryptophan fluorescence spectroscopy, respectively. ANS binding was also performed to 
establish the hydrophobicity of this intermediate species. 
 
Secondary structure 
The far-UV CD spectra of the native and the intermediate states of CLIC1 are shown in 
Figure 14. For comparison, CLIC1 was also incubated in 3.4 M urea at pH 7.0. When CLIC1 
is exposed to 3.4 M urea at pH 7.0, the secondary structure does not change significantly 
compared to native CLIC1 at pH 7.0 (Figure 14). This result is consistent with the fact that 
there is no detectable intermediate species under these conditions. At pH 5.5, however, 
CLIC1 intermediate displays an approximate 40% loss in secondary structure from that of the 
native state at pH 5.5 (Figure 14). 
 
Tertiary structure 
The fluorescence spectra of the native and the intermediate states of CLIC1 are shown in 
Figure 15. At both pH 7.0 and pH 5.5, the fluorescence emission intensities between the 
spectra of native CLIC1 and CLIC1 in the presence of 3.4 M urea do not show a significant 
difference (Figure 15). The maximum emission wavelengths of the spectra of native CLIC1 
and CLIC1 at 3.4 M urea both locate at 345 nm at pH 7.0. However, the maximum emission  
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Figure 14: Comparison of CD spectra of the native and the intermediate state 
Far-UV CD spectra of 2 µM CLIC1 at pH 7.0 (blue) and pH 5.5 (pink) recorded at 20˚C. The 
buffers used: pH 7.0 (50 mM sodium phosphate, 0.02% NaN3, 1 mM DTT) and pH 5.5   
(50 mM sodium acetate, 0.02% NaN3, 1 mM DTT). At pH 7.0, CD spectra of CLIC1 in the 
native state (closed circles) and in the presence of 3.4 M urea (dashed lines) do not display a 
significant difference, indicating a similar secondary structural content. At pH 5.5, the 
intermediate state of CLIC1 at 3.4 M urea only retains approximately 60 % of the secondary 
structure compared to the native state. The spectra of unfolded CLIC1 are indicated with 
solid lines. The spectra were smoothed using the negative exponential methodology 
(SigmaPlot® v11.0). 
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Figure 15: Comparison of tryptophan fluorescence spectra of the native and the 
intermediate state of CLIC1 
Fluorescence spectra of 2 µM CLIC1 at pH 7.0 (blue) and pH 5.5 (pink) recorded at 20˚C. 
The excitation wavelength of the measurements was 280 nm. The buffers used: pH 7.0    
(50 mM sodium phosphate, 0.02% NaN3, 1 mM DTT) and pH 5.5 (50 mM sodium acetate, 
0.02% NaN3, 1 mM DTT). At pH 7.0, CLIC1 in the native state (closed symbols) and in the 
presence of 3.4 M urea (open symbols) do not show a significant difference in either intensity 
or maximum emission wavelength. The spectrum of the intermediate state exhibits a blue 
shift from 345 nm (indicated by the red arrow) to about 340 nm (indicated by the grey arrow) 
at pH 5.5, which indicates a more embedded tryptophan. The spectra of unfolded CLIC1 are 
shown with solid lines. All the spectra were smoothed using the negative exponential 
methodology (SigmaPlot® v11.0). 
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wavelength of the spectra at pH 5.5 shifts from 345 nm in the native state to approximately 
340 nm in the intermediate state (in the presence of 3.4 M urea). This blue shift indicates that 
CLIC1 in the intermediate state has a more embedded tryptophan in the tertiary structure 
when compared to the native state. 
 
ANS binding 
Free ANS in the absence of protein produces a fluorescent peak at 510 nm when excited at 
390 nm. Once ANS binds to hydrophobic clusters on a protein, the maximum emission will 
show a blue shift toward lower wavelength and the intensity will increase largely (Lakowicz, 
2006). Representative spectra of CLIC1 in the presence of ANS at pH 7.0 and pH 5.5 are 
shown in Figure 16. The spectra of CLIC1 show that ANS does not bind to native CLIC1 at 
both pH 7.0 and pH 5.5. Furthermore, ANS does not bind to CLIC1 when in the presence of 
3.4 M urea at pH 7.0 either. This is consistent with the results obtained from the equilibrium 
unfolding studies showing that ANS does not bind to CLIC1 over the entire unfolding 
transition at pH 7.0 (Figure 12D). At pH 5.5, however, the maximum emission wavelength of 
the ANS spectra of the CLIC1 intermediate shifts to 465 nm and the intensity of the emission 
increases significantly, indicating that ANS binds to hydrophobic patches on the surface of 
the CLIC1 intermediate (Figure 16). To conclude, CLIC1 in the intermediate state, which 
forms in the presence of 3.4 M urea at pH 5.5, has far more exposed hydrophobic patches on 
its surface than in the native or the unfolded state at both pH 7.0 and pH 5.5. 
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Figure 16: ANS binds to the intermediate state of CLIC1 
The ANS binding spectra of 2 µM CLIC1 in the native state (open symbols) and in the 
presence of 3.4 M urea (closed symbols) at pH 7.0 (blue) and pH 5.5 (pink) after incubation 
with 200 µM ANS for one hour. Only the spectrum of the CLIC1 intermediate (pH 5.5 and 
3.4 M urea) displays a significant quantum yield when compared to the protein in the native 
state at both pH and in the presence of 3.4 M urea at pH 7.0, indicating that ANS only binds 
to the intermediate state. The excitation wavelength of the spectra is 390 nm. All the spectra 
were corrected for free ANS. The spectra were smoothed using the negative exponential 
methodology (SigmaPlot® v11.0). 
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3.4. Unfolding kinetics 
Unfolding kinetics studies were performed to uncover the unfolding pathway of CLIC1. In 
the equilibrium unfolding studies, CLIC1 follows a two-state unfolding transition at pH 7.0 
while at pH 5.5 it forms an intermediate in the presence of 2.5 ~ 4 M urea (see section 3.3.2.). 
Therefore, the unfolding kinetics studies were divided into three transitions: N →U, N →I 
and I →U, where N, I and U represent the native, the equilibrium intermediate and the 
unfolded states of CLIC1, respectively. CD ellipticity at 222 nm (E222) and fluorescence 
intensity at 345 nm (F345) were used to monitor the rate of unfolding of the secondary and 
tertiary structure, respectively. Since the signals of E222 and F345 show the largest difference 
between native and unfolded CLIC1, these two probes were chosen for clear indication of 
change in structure.  
 
The N →U transition 
CLIC1 was denatured from the native state (N) to the unfolded state (U) by adding the 
protein into urea with a concentration ranging from 5.5 M to 8 M which represents the 
post-transition region of the equilibrium unfolding curves (Figure 12). Representative 
unfolding traces for CLIC1 at pH 7.0 and pH 5.5 at a final urea concentration of 7 M urea are 
shown in Figure 17. For the N →U transition, all the unfolding traces fit to a single 
exponential model without any detectable burst phase at both pH 7.0 and pH 5.5. The urea 
dependence of the unfolding rate constants at pH 7.0 and pH 5.5 was plotted to obtain the 
ku(H2O) and mu values (Figure 18). All the parameters obtained from unfolding kinetic 
studies are shown in Table 3. The unfolding rate in the absence of denaturant, ku(H2O), is an 
estimate of the in vivo unfolding rate of a protein. The mu value gives a measure of the 
amount of surface area exposed in the transition state as a protein unfolds (Myers et al., 
1995).  
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Figure 17: Representative unfolding kinetic traces for the N →U transition at pH 7.0 
and pH 5.5 
The protein was unfolded in the presence of urea at a final concentration of 7 M and the 
structural changes were monitored by F345 (A) and E222 (B) as probes. The solid lines 
represent the fit to a single exponential model at pH 7.0 (blue) and pH 5.5 (pink) and the 
residuals from the fit are also plotted in the panels beneath each figure. The baselines of 
native and unfolded (7 M urea) CLIC1 are indicated in grey and show that no burst phase is 
present.  
 
A 
B 
pH 7.0 pH 5.5 
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Figure 18: Urea dependence of the unfolding rate constants 
A 
B 
N → U 
N → I 
I → U C 
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Unfolding kinetics experiments were performed at 20˚C using circular dichroism ellipticity at 
222 nm (circles) and fluorescence emission at 345 nm (squares as single or fast phase and 
triangles as slow phase) as probes. All the kinetic traces were fitted to either a single or a 
double exponential model. The urea dependence of the unfolding rate constants (kobs) were 
plotted and fitted to a linear regression to acquire the slope (mu values) and apparent 
unfolding rate in the absence of denaturant, ku(H2O). (A) Unfolding of the N →U transition at 
pH 7.0 (blue) and pH 5.5 (pink). (B) Unfolding of the N → I transition. (C) Unfolding of the 
I →U transition. 
 
 
Table 3: Parameters for the unfolding kinetics of CLIC1 at pH 7.0 and pH 5.5 
 
mu (kcal/mol/M urea) ku(H2O) (min-1)   
CD Fluorescence CD Fluorescence 
 
pH 7.0 
 
N →U 
 
0.19 ± 0.02 
 
0.21 ± 0.03 
 
5.6×10-3  
(± 1.8×10-3) 
 
6.1×10-3  
(± 2.4×10-3) 
  
N →U 
 
0.37 ± 0.01 
 
0.15 ± 0.01 
 
4.8×10-3 
(± 8.8×10-4) 
 
0.4 
(± 0.08) 
 
pH 5.5 
 
N → I 
 
0.97 ± 0.07 
Fast phase: 
-0.13 ± 0.22 
Slow phase: 
-0.15 ± 0.14 
 
2.3×10-5 
(± 1.3×10-5) 
First phase: 
1.9 ± 2.2 
Second phase: 
0.17 ± 0.31 
  
I →U 
 
0.47 ± 0.03 
Fast phase: 
0.42 ± 0.09 
Slow phase: 
0.45 ± 0.04 
 
6.3×10-4  
(±3.1×10-4) 
Fast phase: 
4.6×10-3  
(± 6.3×10-3) 
Slow phase: 
 7.9×10-4  
(± 5.1×10-4) 
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At pH 7.0, the ku(H2O) and mu values of CD- and fluorescence-monitored unfolding are 
similar indicating that the secondary and tertiary structure of CLIC1 unfold at a similar rate 
(Table 3), although the CD-monitored unfolding is slightly slower. This phenomenon might 
result from the fact that CD at 222 nm monitors global changes of an entire protein while 
fluorescence monitors local environmental changes near the lone tryptophan. 
 
At pH 5.5, if only comparing the ku(H2O) of the fluorescence-monitored unfolding with the 
ku(H2O) of both the CD and fluorescence data at pH 7.0, the unfolding rate of CLIC1 is much 
faster than at pH 7.0. However, the ku(H2O) from the CD data at pH 5.5 shows a very similar 
value to the values obtained at pH 7.0 (Table 3). CLIC1 is a predominantly α-helical protein 
and the far-UV CD spectra of CLIC1 show a pattern typical of α-helical proteins with two 
minima at 208 and 222 nm. CLIC1 has two domains: the smaller N-domain with mixture of 
α-helices and β-strands and the bigger all-helical C-domain. Therefore, the majority of 
E222-monitored signals comes from the bigger all-helical C-domain. Hydrogen-deuterium 
exchange has demonstrated that at pH 5.5 the N-domain becomes more flexible than at    
pH 7.0 (Stoychev et al., 2009). In contrast, the C-domain is not really influenced by the low 
pH. In unfolding kinetics, the similar ku(H2O) of the CD-monitored unfolding at both pH 
values might suggest that in the absence of denaturant, the stability of the C-domain is not 
influenced by pH. The large mu value of the CD-monitored data at pH 5.5 indicates a large 
increase in solvent accessibility of CLIC1 upon unfolding. This result might suggest 
C-domain is more compact than the N-domain in the absence of urea at pH 5.5. On the other 
hand, the fluorescence monitors the changes in local tertiary structure where the tryptophan 
residues are located. In the case of CLIC1, the lone tryptophan, Trp35, locates in the 
N-domain and thus the fluorescence is able to monitor changes specifically in the N-domain. 
In contrast with the large mu value obtained from CD-monitored data, the smaller mu value 
obtained from fluorescence-monitored unfolding might suggest that the conformation of the 
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N-domain is less compact at pH 5.5 and thus the N-domain exposes less solvent accessible 
area compared to the C-domain upon unfolding. Moreover, this significant difference 
between the mu values of CD and fluorescence-monitored unfolding is only detected at pH 5.5. 
Although the CD- and fluorescence-monitored unfolding traces at pH 5.5 both show a 
single-phasic transition, this mu value difference suggests the existence of hidden 
intermediate species appearing in the unfolding reaction at this pH which is confirmed by the 
equilibrium work (Bhuyan and Udgaonkar, 1998). 
 
The N →I transition 
CLIC1 was denatured from the native state (N) to the intermediate state (I) by adding the 
protein into buffers with a final urea concentration ranging from 3 M to 4 M at pH 5.5 which 
represents the condition that the intermediate state forms at equilibrium (Figure 12). 
Representative unfolding traces are shown in Figure 19. The CD-monitored traces fit well to 
a single exponential model. However, the fluorescence-monitored unfolding kinetics of the 
N → I transition is no longer monophasic. Hypofluorescence is initially detected and 
separates the unfolding traces into a clear biphasic transition as the protein unfolds (Figure 
19). Therefore, the fluorescence-monitored kinetic traces were fit to two separate single 
exponential models. The ku(H2O) values of the first and second detected phase show that the 
first phase proceeds at a faster rate when compared to the second phase (Figure 18 and Table 
3). The mu value of the CD-monitored data is large (Figure 18 and Table 3), indicating that 
the structure of CLIC1 in the N → I transition is very sensitive to urea concentration. 
Moreover, the large mu value of the CD-monitored data indicates that the global structure of 
the intermediate has a much more exposed surface area compared to native CLIC1. However, 
the mu values of both fluorescence-monitored phases show negative trends (Figure 18), 
suggesting that the local tertiary structure (where Trp35 locates) of the intermediate is 
changed and Trp35 becomes more embedded compared to that of the native state of CLIC1. 
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Figure 19: Representative unfolding kinetic traces of CLIC1 from the N → I transition 
at pH 5.5 
CLIC1 (2 µM) was unfolded from the native state to a final concentration of 3.4 M urea. The 
traces were monitored using both F345 (A) and E222 (B) as probes. The solid lines represent the 
fit to a single (B) or two separate single (A) exponential models and the residuals are plotted 
in the panels beneath each figure. The baselines of the native and the intermediate states are 
indicated in grey (A) and by arrows (B). 
A 
B 
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This observation is consistent with the fluorescence spectra that show that CLIC1 has a more 
buried tryptophan in the intermediate state (Figure 15). 
 
The I →U transition 
For this study, CLIC1 was firstly incubated in the presence of 3.4 M urea at pH 5.5 which 
corresponds to the condition that the most intermediate species accumulates (Figure 13) for 1 
hour in order to obtain the stable equilibrium intermediate species. The intermediate was then 
unfolded in the presence of a final concentration of 5.6 M to 7 M urea. Representative 
unfolding traces are shown in Figure 20. The CD-monitored traces fit to a single exponential 
model without any detectable burst phase. However, the fluorescence-monitored traces fit to 
a double exponential model, indicating that there are two kinetic phases. The two phases 
monitored by fluorescence are similar in their mu values (Figure 18 and Table 3), indicating a 
similar amount of surface area exposed as the protein unfolds in the two phases. Both the 
fluorescence-monitored phases have similar urea-dependence on the rate constants to the 
CD-monitored data. The ku(H2O) of the CD-monitored unfolding, however, is only similar to 
the one from the fluorescence-monitored slow phase. This suggests that CD is only able to 
record this slow phase. 
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Figure 20: Representative unfolding kinetic traces of the I →U transition 
CLIC1 (2 µM) was incubated in the presence of 3.4 M urea at pH 5.5, then unfolded in the 
presence of a final concentration of 7 M urea. The traces were monitored using both F345 (A) 
and E222 (B) as probes. The solid lines represent the fit to a single (B) or a double (A) 
exponential model and the residuals are plotted in the panels beneath each figure. The 
baselines of the intermediate (3.4 M urea) and the unfolded CLIC1 (7 M urea) are indicated 
in grey. 
A 
B 
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4. Discussion 
CLICs are channel proteins which have distinct properties from traditional channel proteins. 
The most unusual one is that, unlike typical channel proteins, they do not insert into 
membranes cotranslationally. Instead, CLIC proteins are translated as soluble proteins in the 
cytosol without leader sequences to direct them to insert into membranes (reviewed by Singh, 
2010). An as yet unknown signal directs the protein from the cytosol to the membrane where 
it changes conformation from a soluble form to a transmembrane protein. The main question 
that puzzles many scientists is how CLIC1 converts between soluble and membrane-bound 
forms. In its transition from a fully folded soluble protein to a membrane-bound protein, 
CLIC1 has been hypothesised to unfold or at least partially unfold in order to insert into the 
membrane (Littler et al., 2010). However, the exact mechanism of this conversion is still 
unknown. Therefore, in an attempt to get insight into the conversion between CLIC1 soluble 
and membrane-bound states, the unfolding mechanism of soluble CLIC1 was investigated at 
the pH values typical of the cytosol and the membrane surface. 
 
4.1. A stable equilibrium intermediate state of CLIC1 is 
formed at pH 5.5 
The equilibrium unfolding studies of CLIC1 were conducted at pH 7.0 and pH 5.5 which 
correspond to the pH values in cytosol and near the surface of membranes (McLaughlin, 
1989), respectively. At pH 5.5, under mild denaturing conditions, CLIC1 forms a stable 
equilibrium intermediate species which is unlike its native state or unfolded state, while there 
is no intermediate formed at pH 7.0 (Figure 12). 
 
At low pH (pH 4.0 or lower), the channel peptide of the bacterial channel-forming toxin, 
colicin E1, has been shown to transit into an insertion-competent state (Merrill et al., 1990; 
 87 
Merrill et al., 1993; Schendel and Cramer, 1994). These toxins have a similar property to 
CLIC1: they are also translated as soluble forms and transform into their membrane-bound 
forms once they reach their targets (Parker and Feil, 2005). The insertion-competent state of 
colicin E1 increases the exposure of the peptide’s hydrophobic core due to structural 
rearrangements. Moreover, it has been reported that low pH acts as a general trigger to 
activate the membrane-insertion mechanism for these bacterial pore-forming toxins (Musse 
and Merrill, 2003). The mechanism starts with the structures of the toxins becoming 
destabilised at low pH (corresponding to the pH level at the membrane surface) and forming 
molten globule-like intermediate states. The “molten globule” is characterised by native-like 
secondary structure with a poorly defined tertiary structure (Ptitsyn, 1995) and binds to the 
hydrophobic dye ANS which is how it can be detected (Banerjee and Kishore, 2005). Since 
the structure of these molten globule-like intermediates is more flexible and hydrophobic, it 
also lowers energy barriers needed for exposure of the buried hydrophobic helices and for 
interaction with membranes in order to facilitate membrane-insertion (Parker and Feil, 2005).  
 
Is the equilibrium intermediate of CLIC1 a “molten globule” state? 
In the case of CLIC1, an intermediate state is formed at pH 5.5 in the presence of 3 ~ 4 M 
urea. Moreover, ANS is also able to bind to this intermediate state of CLIC1 (Figure 16). 
Therefore, since the intermediate state forms under mild denaturing conditions and it has 
exposed hydrophobic surface, it is suspected to be in a molten globule-like state. The CLIC1 
intermediate state has approximately 60% secondary structure when compared to the native 
CLIC1 (Figure 14). The fluorescence spectra of the CLIC1 intermediate show neither 
increased nor decreased fluorescence intensity when compared to the native state. This 
suggests that the compactness of CLIC1 tertiary structure in the intermediate state does not 
change significantly compared to the native state. The only difference in the spectra between 
the native and intermediate state is that, the maximum emission wavelength of the 
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intermediate shows a slight blue shift from 345 nm to 340 nm, indicating that the single 
tryptophan, Trp35, is more embedded in the protein than it is in the native state. The 
observations from fluorescence spectra indicate that the CLIC1 intermediate still has a 
well-defined tertiary structure and is even more compact in the environment around the lone 
tryptophan residue than in the native state. The reduced secondary and the well-packed 
tertiary structure of the intermediate state make it fall out of the definition of “molten 
globule”. Therefore, CLIC1 does not form a molten globule-like equilibrium intermediate 
state that is true to the definition as the colicins do.  
 
The hydrophobicity of the intermediate 
Previous studies have proposed that it is likely that the membrane-docking form of CLIC1 
has exposed hydrophobic surface area (Littler et al., 2010). In this study, ANS binding studies 
show that the intermediate state of CLIC1 also has more hydrophobic area on its surface than 
in the native state (Figure 16). Whether this equilibrium intermediate of CLIC1 is a 
membrane-competent form or not, still remains to be determined. However, the 
hydrophobicity of the intermediate clearly has potential to enable the protein to interact with 
highly hydrophobic biological membranes when in this state. 
 
The low pH-induced destabilisation of CLIC1 
Even though CLIC1 does not form an intermediate that is true to the definition of “molten 
globule”, it is likely that the structural transition between soluble and membrane-insertable 
CLIC1 might involve intermediate states and might also be induced by low pH in a similar 
way to the colicins. It has been demonstrated that the pH-activated membrane-insertion 
mechanism of colicin E1 involves protonation of some acidic residues which form a 
pH-sensitive motif, resulting in disruption of some critical hydrogen bonds and salt bridges 
which further loosen the tertiary structure for membrane-insertion (Musse and Merrill, 2003). 
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In the N-domain of CLIC1, there are two salt bridges (Arg29-Glu81 and Lys37-Glu85), and 
one formed across the domain interface (Lys20-Asp225). Arg29 in helix α1 forms a salt 
bridge and a hydrogen bond with Glu81 in helix α3 while Asn78 forms hydrogen bonds with 
both Arg29 and Glu81. It has been reported that, at acidic pH, the N-domain of CLIC1, 
especially in the putative transmembrane region, becomes more flexible than at neutral pH 
(Stoychev et al., 2009). Also, breaking the salt bridge between Arg29 and Glu81 via R29M 
and E81M single mutants as well as the R29M/E81M double mutant, has been shown to 
decrease the conformational stability of the N-domain (Legg E’Silva PhD thesis, 2011), 
indicating that the salt bridge and the hydrogen bond are responsible for the stabilisation of 
the N-domain. Moreover, hydrogen-deuterium exchange studies of CLIC1 shows that the 
residues in these salt bridges (Arg29-Glu81, Lys37-Glu85 and Lys20-Asp225) are located in 
the two segments (peptide 11-31 and peptide 68-82) that display the highest exchange rate at 
pH 5.5 (Stoychev et al., 2009). Therefore, at pH 5.5 (roughly the pH at the membrane 
surface), protonation of these acidic residues causes critical salt bridges and hydrogen bonds 
in the N-domain and in the domain interface to break, leading to structural flexibility in the 
N-domain. This flexibility of the N-domain is able to reduce the energy barrier for the 
structural transition from the soluble protein to the membrane-competent conformation and is 
further able to facilitate the membrane insertion of CLIC1. 
 
4.2. Unfolding of CLIC1 
The equilibrium unfolding of CLIC1 has revealed that CLIC1 unfolds via a two-state 
mechanism at pH 7.0 and via a three-state mechanism with an appearance of an equilibrium 
intermediate at pH 5.5. Therefore, in order to detect the transient intermediate species and to 
obtain more information on the mechanism of unfolding, CLIC1 unfolding kinetics were 
conducted by unfolding CLIC1 from the native state to the unfolded state and the 
 90 
intermediate state, and also unfolded from the intermediate state to the unfolded state. 
 
4.2.1. The appearance of hidden intermediates in the N→U transition 
At pH 7.0, unfolding of native CLIC1 monitored by fluorescence and CD both show a 
single-phasic transition. The similar mu values obtained from both probes (Table 3) further 
suggest that there is no detectable intermediate in the process of unfolding the native CLIC1 
at pH 7.0. At pH 5.5, CLIC1 also demonstrates single-phasic unfolding kinetics traces when 
monitored using both probes. However, the non-coincidence of the mu values obtained from 
the fit of CD- and fluorescence-monitored unfolding kinetics suggests the existence of 
“hidden intermediate species” along the unfolding reaction (Bhuyan and Udgaonkar, 1998). 
The single-phasic transition of both the CD- and fluorescence-monitored kinetic traces might 
result from the fact that under these strong denaturing conditions (5.5 ~ 7 M urea) the hidden 
transient intermediates of CLIC1 in the N →U transition are less stable than the unfolded 
state (Bai, 2003) and thus they cannot be significantly populated and detected by the probes 
used during the unfolding process. In addition, the unfolding kinetic studies of the N →U 
transition further show that the intermediate state (including hidden intermediates) only forms 
at pH 5.5, which is same as with the equilibrium unfolding studies. However, in this study, 
we do not have enough information to conclude that the hidden transient intermediate formed 
in the unfolding transition between the native and unfolded state and the intermediate formed 
at equilibrium under mild denaturing conditions are identical. 
 
4.2.2. The equilibrium intermediate is more stable than the native state at 
pH 5.5 
Unfolding of the equilibrium intermediate state (the I → U transition) monitored by 
fluorescence occurs in two phases: a fast phase and a slow phase. The appearance of two 
kinetic phases generally suggests that three species appear along this unfolding transition.  
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Although fluorescence-monitored unfolding of the intermediate state displays two kinetic 
phases, the CD-monitored unfolding only shows a single phase. Since CD is a probe used to 
monitor change in global secondary structure, it might not be as sensitive as fluorescence to 
the local structural change around Trp35 in the N-domain when the equilibrium intermediate 
unfolds. When comparing the ku(H2O) of the CD-monitored unfolding of the native and 
intermediate states, the intermediate state is shown to unfold at a slower rate than the native 
state in the absence of denaturant at pH 5.5 (Table 3), indicating that the intermediate appears 
to be more stable than the native state at this pH. The same result can be seen in the 
equilibrium unfolding studies where the ∆G(H2O) for the I →U transition at pH 5.5 is larger 
than the ∆G(H2O) for the N → I transition at pH 5.5 or the N →U transition at pH 7.0  
(Table 2). This may imply that, at pH 5.5, the native state is destabilised and the intermediate 
of CLIC1 is more energically favoured than the native state under this condition.  
 
4.2.3. Formation of the equilibrium intermediate 
When using fluorescence as a probe to monitor CLIC1 unfolding from the native state to the 
equilibrium intermediate state (the N → I transition), a hypofluorescence minimum occurs 
and separates the unfolding into two clear kinetic phases (Figure 19). The 
fluorescence-monitored unfolding traces of the N → I transition occur initially with a fast 
decrease in intensity followed by a gradual increase in intensity. These two kinetic phases 
both fit to a single exponential model. Although we cannot be certain how many species are 
involved in this transition, the observation of two phases suggests that there are likely three 
species involved in the N → I transition of CLIC1 (Utiyama and Baldwin, 1986). 
 
The first phase in the formation of the CLIC1 intermediate displays a decrease in 
fluorescence intensity, indicating the likelihood of an unfolding reaction. Unfolding processes 
often increase the distance between the tyrosine and tryptophan residues in the same protein, 
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and disrupt the FRET between these residues and further cause the fluorescence intensity of 
the protein to decrease (Lakowicz, 2006), although it is certainly possible to get an increase 
in fluorescence intensity upon unfolding. After the first rapid unfolding, the second phase 
displays a slight increase in fluorescence intensity slower than the first phase. For the data, 
we are unable to state conclusively whether these two kinetic phases occur in sequence or in 
parallel. However, from the fractional population plot obtained from equilibrium unfolding, 
at 3 to 4 M urea at pH 5.5, majority of the species is in the intermediate state (Figure 13). 
Also, the equilibrium intermediate shows a compact tertiary structure when compared to the 
native state. It is likely that the enhanced fluorescence intensity in the second phase results 
from the fact that the unfolded structure of CLIC1 somehow refolds, recovering the FRET 
between the tryptophan and the tyrosine residues and thus increasing the fluorescence 
intensity at 345 nm. Moreover, the negative mu values of these two phases suggest that the 
structure of CLIC1 in the intermediate state, especially around Trp35, becomes more compact 
than the native state (Table 3). This observation is consistent with the results obtained from 
the equilibrium unfolding studies where the spectra of the equilibrium intermediate show that 
Trp35 becomes more buried in the intermediate state than in the native state. Therefore, these 
two kinetic phases might be interpreted to be a sequential process: the increase in 
fluorescence intensity in the second phase represents a slow repacking or rearrangement of 
the protein structure after the fast unfolding reaction shown in the first phase (Steer and 
Merrill, 1997).  
 
Slow reactions in unfolding processes of proteins can be caused by formation of disulfide 
bonds. All the unfolding kinetics experiments in this study were performed in the presence of 
1 mM DTT. Under reducing conditions, CLIC1 is unable to form either intermolecular or 
intramolecular disulfide bonds. Therefore, it is unlikely that the slow rearrangement of 
CLIC1 structure after the rapid unfolding is due to disulfide bonds formation. On the other 
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hand, the proline isomerisation process is also a cause of slow steps in unfolding reactions but 
it often cannot be detected using usual spectroscopic methods. However, it can be measured 
using a “double-jump” assay. This method relies on the fact that proline isomerisation is a 
slow process and the refolding rate of the Uf →N and the Us →N transitions are thus different 
(Brandts et al., 1975; Schmid, 1986), where Uf and Us represent unfolded species with native 
and non-native prolyl isomers, respectively. Proline isomerisation in unfolding reactions can, 
therefore, be detected and monitored. Generally “double-jump” assays can be performed 
using stopped-flow techniques. However, in this study, the unfolding kinetics studies were 
conducted using a manual mixing method and thus, unfortunately, “double-jump” assays 
were not able to be performed. Therefore, whether this slow structural rearrangement is 
caused by proline isomerisation or not, remains to be determined. In addition, after rapid 
unfolding, hydrophobic residues of partially unfolded protein are exposed to the polar solvent 
and thus they are prone to interact with each other and become buried again in order to get 
away from the solvent. Therefore, the hydrophobic interaction among residues might also be 
one of the possible forces that drive the repacking of the partially unfolded CLIC1. Combined 
with the assumptions that there are three species involved in this reaction and that the 
reaction occurs in sequence, a pathway of the N → I transition can thus be described as an 
initial rapid unfolding of native CLIC1 to a partially unfolded structure, followed by a slow 
rearrangement of CLIC1 structure to form the equilibrium intermediate.  
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4.2.4. Unfolding pathway of CLIC1 
Unfortunately, from the limited data, there is no clear evidence to conclude either that the 
equilibrium intermediate is on- or off-pathway or that the hidden intermediate species formed 
in the N →U transition at pH 5.5 are the same species as the equilibrium intermediate. The 
overall view of the unfolding pathway that is derived from the results in this study is 
summarised in Figure 21. At pH 7.0, which corresponds to the pH value in the cytosol, 
CLIC1 unfolds from the native state to the unfolded state without any detectable 
intermediates. At pH 5.5, which corresponds to the pH value near the membrane surface, the 
unfolding of CLIC1 from the native state to the unfolded state occurs in a single phase, but 
this unfolding transition is accompanied by unstable hidden intermediate species.  
 
The formation of the equilibrium intermediate occurs in two phases. Native CLIC1 unfolds 
rapidly in the first phase to form a partially unfolded structure. In the second phase, the 
partially unfolded structure of CLIC1 repacks due to unknown interactions among residues 
and rearranges to form the native-like equilibrium intermediate state gradually. The partially 
unfolded equilibrium intermediate with more exposed hydrophobic area than native CLIC1 
(Figure 16) then might be able to serve as a precursor to membrane docking (Littler et al., 
2010). The free energy required to form the equilibrium intermediate is the least among three 
transitions (N →U, N → I and I → U) and thus, at pH 5.5 CLIC1 is prone to form the 
equilibrium intermediate from the native state (Table 2). 
 
The unfolding of the intermediate state occurs in two phases: a fast and a slow phase. 
However, we are unable to state conclusively whether the two phases in the I →U transition 
are sequential or parallel. The free energy needed for this transition is the highest among 
three transitions (Table 2). This further confirms that the intermediate state is fairly stable at 
pH 5.5 when compared to the native and unfolded states at both pH. 
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Figure 21: Proposed unfolding pathway of CLIC1  
Possible unfolding scheme for CLIC1 at 20˚C. The arrows with solid line and dashed line 
represent fast/faster and slow/slower phases, respectively. At pH 7.0, the protein unfolds from 
the native state (N) to the unfolded state (U) in a single-phasic transition without formation of 
any detectable intermediate. However, at pH 5.5, the unfolding of CLIC1 occurs in a fast 
phase with hidden intermediate species. In the formation of the native-like equilibrium 
intermediate (Ieq) at pH 5.5, N unfolds to a partially unfolded form (Up) in a fast phase and 
then restructures to form the stable equilibrium intermediate in a slow phase. The unfolding 
of the intermediate state occurs in a fast and a slow phase. However, whether these two 
phases occur sequentially or in parallel, remains unknown. 
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4.3. Proposed CLIC1 insertion mechanism 
The signal that triggers CLIC1 to insert into membranes is still unclear. Both oxidation and 
low pH have been shown to increase the channel forming activity of CLIC1 in artificial 
bilayers (reviewed by Singh, 2010). However, it is unlikely that either oxidation or low pH 
can be the only control for CLIC1 insertion (Littler et al., 2010). Therefore, it is possible that 
the function of these two factors is cooperative. In this study, the focus is on how the different 
pHs, typical of the cytosol and the membrane surface, can influence the unfolding behaviour 
of soluble CLIC1 in the absence of the membranes. 
 
At pH 7.0 (cytosol), the equilibrium unfolding and the unfolding kinetics of soluble CLIC1 
both show that CLIC1 is relatively stable and neither equilibrium nor transient intermediates 
are detectable so unfolding is highly cooperative. At pH 5.5 (membrane surface), the structure 
of soluble CLIC1 becomes more flexible (Stoychev et al., 2009), the native state is 
destabilised and a stable equilibrium intermediate forms. Therefore, at pH 5.5, it is likely that 
the energy barrier needed for the structural transition between soluble and 
membrane-competent form is reduced. The membrane insertion of CLIC1, therefore, 
becomes accessible more easily due to the reduced energy barrier. 
 
The possible insertion mechanism of CLIC1 has been proposed previously in the literature 
(Littler et al., 2010). Applying the results of CLIC1 differential unfolding behaviour at 
various pHs obtained in this study to the previously proposed CLIC1 membrane insertion 
mechanism, a hypothetical scheme of CLIC1 insertion is shown in Figure 22. Since there is 
no membrane work involved in this study, the mechanism for the membrane insertion and the 
pore formation of CLIC1 proposed in the following is simply a hypothesis. 
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Figure 22: Proposed membrane insertion model of CLIC1  
The C-domain and PTMD are indicated in green and blue, respectively. In the cytosol where 
the pH is close to 7.0, CLIC1 exists in its soluble form which is a monomeric conformation. 
Once the soluble CLIC1 is stimulated by a certain signal or stress, CLIC1 monomers move 
close to the membrane surface where the pH is 5.5 and are protonated by hydrogen ions on 
the membrane surface. The protonation destabilises the structure of the soluble CLIC1 
monomer, causing a rapid unfolding of the structure followed by a restructuring to form the 
membrane docking form. The membrane docking structure possesses exposed hydrophobic 
areas on its surface and thus has the ability to interact with the membrane. After the docking 
process, the PTM region inserts into the membrane. CLIC1 integral monomers then 
oligomerise to form a functional ion channel. 
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Under normal conditions, CLIC1 is in the cytosol, stable and soluble. Once there is a signal 
(could be oxidation or another unknown signal) to activate CLIC1 insertion, CLIC1 moves 
close to the membrane surface. The local low pH at the membrane surface then destabilises 
the structure of CLIC1 by breaking critical salt bridges, resulting in a more flexible and 
destabilised structure, and allowing CLIC1 to convert into the membrane-docking form 
(Figure 22).  
 
The equilibrium intermediate is likely to have similar properties to the membrane-docking 
form of CLIC1, in terms of flexibility and hydrophobicity. The unfolding kinetics of the 
N → I transition shows the most significant result of this study. After destabilisation by the 
local low pH, CLIC1 goes through a rapid unfolding process followed by a gradual 
rearrangement of the structure to form the intermediate with exposed hydrophobic surface 
areas. The membrane-docking form has thus reduced the energy barrier to the interaction 
with and insertion of soluble CLIC1 into membranes. 
 
After membrane docking, CLIC1 inserts into the membrane with the PTMD embedded in the 
lipid bilayer. In order to form a functional channel and to conduct the complete function of 
the protein, the integral CLIC1 with only one transmembrane helix is likely to form an 
oligomer (Singh, 2010). It has been proposed that the CLIC1 membrane-competent form 
might form an oligomer before insertion into membranes (McIntyre, PhD thesis). In this 
study, because of the exposure of the hydrophobic areas, the equilibrium intermediate has the 
potential to form oligomeric structure through hydrophobic interaction. However, this cannot 
be concluded without further experiments. Although dimeric CLIC1 is able to insert into 
artificial membranes, oligomerisation is still more likely to happen after monomeric CLIC1 
inserts into membranes due to the fact that the pre-insertion oligomeric form of CLIC1 might 
cause steric hindrance to the insertion process (Littler et al., 2004).  
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4.4 Conclusions 
The focus of this study was to examine the effect of the pH typical of the cytosol and 
membrane surface on the unfolding mechanism of soluble CLIC1. It was found in this study 
that the unfolding behaviour of soluble CLIC1 is different under different conditions.  
 
Unfolding of CLIC1 is cooperative at pH 7.0 without either equilibrium or transient 
intermediates detected. At pH 7.0, the unfolding of native CLIC1 occurs at a significantly 
slower rate than at pH 5.5. This indicates that the conformational stability of CLIC1 is 
reduced at low pH when compared to neutral pH. This destabilisation might result from the 
breakage of critical stabilising salt bridges and hydrogen bonds by protonation at low pH. 
The low pH also leads CLIC1 to unfold following a different pathway with the existence of 
intermediate species. At pH 5.5, equilibrium unfolding and unfolding kinetics studies 
demonstrate that both stable intermediate species and transient hidden intermediate species 
are populated during the transition, respectively. 
 
It has been proposed that CLIC1 needs to unfold and refold in order to form a 
membrane-competent form to interact with or insert into the membrane. It can be seen in this 
study that at pH 5.5 CLIC1 experiences a rapid unfolding and a slow refolding to form the 
equilibrium intermediate state which is proposed to be a membrane-competent form of the 
protein. This result appears to be in agreement with the proposal that CLIC1 converts 
between two conformations by the unfolding and refolding process.  
 
Although the results of this study provide some information and hypotheses toward the 
membrane insertion mechanism of CLIC1, a number of questions still remain unanswered. Is 
the equilibrium intermediate state of CLIC1 really the membrane-competent form of the 
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protein? All the unfolding kinetics studies in this study were conducted at 20˚C. What will 
the unfolding kinetics be like if the experiments are performed at 37˚C, the physiological 
temperature of human bodies? In this study, unfolding kinetics studies were performed using 
a manual mixing method which might not only limit the monitoring of fast events in the early 
stage of unfolding but also limit the detection of proline isomerisation reactions. Further 
unfolding kinetics studies can be conducted using a stopped-flow technique in order to detect 
fast events or to detect proline isomerisation using “double-jump” assays. The initial 
conditions tests can also be performed for more information about whether the pathways 
occur sequentially or in parallel to supplement the existing knowledge. Also, CLIC1 has only 
one tryptophan residue located in the putative transmembrane region in the N-domain. The 
lone tryptophan, Trp35, is advantageous because it enables us to monitor the structural 
changes specifically in the transmembrane region and the N-domain by using tryptophan 
fluorescence spectroscopy during the unfolding process. However, the lone tryptophan also 
restricts the observation of changes in the C-domain. What role does the C-domain play 
during the unfolding process? Although CD is a technique that is able to monitor a global 
structural change, tryptophan bears an advantage to monitor the local environment. Therefore, 
locating a tryptophan in the C-domain and knocking out the one in the N-domain by 
mutations can be done to monitor any structural changes in the C-domain to complement the 
current results obtained from the single tryptophan Trp35. 
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